<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680437</article-id><article-id pub-id-type="doi">10.3390/v16121839</article-id><article-id pub-id-type="publisher-id">viruses-16-01839</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Tissue-Specific DNA Methylation Changes in CD8<sup>+</sup> T Cells During Chronic Simian Immunodeficiency Virus Infection of Infant Rhesus Macaques</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3439-9318</contrib-id><name><surname>Nag</surname><given-names>Mukta</given-names></name><xref rid="af1-viruses-16-01839" ref-type="aff">1</xref><xref rid="af2-viruses-16-01839" ref-type="aff">2</xref><xref rid="c1-viruses-16-01839" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Fogle</surname><given-names>Jonathan E.</given-names></name><xref rid="af3-viruses-16-01839" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Pillay</surname><given-names>Santhoshan</given-names></name><xref rid="af2-viruses-16-01839" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6180-5361</contrib-id><name><surname>Del Prete</surname><given-names>Gregory Q.</given-names></name><xref rid="af1-viruses-16-01839" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5199-3004</contrib-id><name><surname>De Paris</surname><given-names>Kristina</given-names></name><xref rid="af2-viruses-16-01839" ref-type="aff">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Derdeyn</surname><given-names>Cynthia</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Sodora</surname><given-names>Donald</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Manuzak</surname><given-names>Jennifer A.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Derby</surname><given-names>Nina</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-16-01839"><label>1</label>AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA</aff><aff id="af2-viruses-16-01839"><label>2</label>Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA<email>kristina_abel@med.unc.edu</email> (K.D.P.)</aff><aff id="af3-viruses-16-01839"><label>3</label>Boehringer Ingelheim Animal Health, Athens, GA 30601, USA</aff><author-notes><corresp id="c1-viruses-16-01839"><label>*</label>Correspondence: <email>mukta.nag@nih.gov</email>; Tel.: +1-301-846-7698</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>16</volume><issue>12</issue><elocation-id>1839</elocation-id><history><date date-type="received"><day>28</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>24</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>26</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Robust CD8<sup>+</sup> T cell responses are critical for the control of HIV infection in both adults and children. Our understanding of the mechanisms driving these responses is based largely on studies of cells circulating in peripheral blood in adults, but the regulation of CD8<sup>+</sup> T cell responses in tissue sites is poorly understood, particularly in pediatric infections. DNA methylation is an epigenetic modification that regulates gene transcription. Hypermethylated gene promoters are associated with transcriptional silencing and, conversely, hypomethylated promoters indicate gene activation. In this study, we evaluated DNA methylation signatures of CD8<sup>+</sup> T cells isolated from several different anatomic compartments during pediatric AIDS-virus infection by utilizing the SIV<sub>mac239/251</sub> infected infant rhesus macaque model. We performed a stepwise methylation analysis starting with total cellular DNA, to immunomodulatory cytokine promoters, to specific CpG sites within the cytokine promoters in CD8<sup>+</sup> T cells isolated from peripheral blood, lymph nodes, and intestinal tissue during the chronic phase of infection. Tissue-specific methylation patterns were determined for transcriptionally active promoters of key immunomodulatory cytokines: interferon gamma (IFN&#x003b3;), interleukin-2 (IL-2), and tumor necrosis factor alpha (TNF&#x003b1;). In this study, we observed tissue-specific differences in CD8<sup>+</sup> T cell modulation by DNA methylation in SIV-infected infant macaques, highlighting the importance of evaluating cells from both blood and tissues to obtain a complete picture of CD8<sup>+</sup> T cell regulation during pediatric HIV infection.</p></abstract><kwd-group><kwd>CD8<sup>+</sup> T cells</kwd><kwd>DNA methylation</kwd><kwd>pediatric HIV infection</kwd><kwd>pediatric SIV infection</kwd><kwd>infant rhesus macaque model</kwd><kwd>tissue-specific methylation</kwd><kwd>tissue-specific cytokine regulation</kwd></kwd-group><funding-group><award-group><award-id>NIH R01 DE028146</award-id></award-group><award-group><funding-source>UNC Center for AIDS Research</funding-source><award-id>CFAR; P30 AI50410</award-id></award-group><award-group><funding-source>UNC CFAR Developmental</funding-source></award-group><award-group><funding-source>National Cancer Institute, National Institutes of Health</funding-source><award-id>75N91024F00011/75N91019D00024</award-id></award-group><funding-statement>This study was funded by NIH R01 DE028146 awarded to K.D.P., supported by the UNC Center for AIDS Research (CFAR; P30 AI50410) and the UNC CFAR Developmental Award to J.E.F., and in part by federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. 75N91024F00011/75N91019D00024. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-16-01839"><title>1. Introduction</title><p>CD8<sup>+</sup> T cells are key mediators of viremia control during HIV/SIV infections. The involvement of CD8<sup>+</sup> T cells in viral control is evidenced by the concurrent emergence of virus-specific CD8<sup>+</sup> T cells during peak viremia resolution in the acute phase of infection, the increase in viremia that follows experimental depletion of CD8<sup>+</sup> T cells in SIV-infected rhesus macaques in both acute and chronic phases of infection, and the selection of viral CTL-escape mutations in response to the immunological pressure exerted by CD8<sup>+</sup> T cells [<xref rid="B1-viruses-16-01839" ref-type="bibr">1</xref>,<xref rid="B2-viruses-16-01839" ref-type="bibr">2</xref>,<xref rid="B3-viruses-16-01839" ref-type="bibr">3</xref>,<xref rid="B4-viruses-16-01839" ref-type="bibr">4</xref>,<xref rid="B5-viruses-16-01839" ref-type="bibr">5</xref>,<xref rid="B6-viruses-16-01839" ref-type="bibr">6</xref>,<xref rid="B7-viruses-16-01839" ref-type="bibr">7</xref>]. In addition, specific MHC class I alleles, HLA B*27 and B*57, are associated with elite control of HIV viral replication, with HLA B*27- and B*57-positive elite controllers shown to possess high frequencies of virus-specific CD8<sup>+</sup> T cells restricted by these class I alleles [<xref rid="B8-viruses-16-01839" ref-type="bibr">8</xref>,<xref rid="B9-viruses-16-01839" ref-type="bibr">9</xref>,<xref rid="B10-viruses-16-01839" ref-type="bibr">10</xref>,<xref rid="B11-viruses-16-01839" ref-type="bibr">11</xref>]. Akin to humans, elite control of SIV replication in rhesus macaques is associated with MHC class I alleles Mamu B*08 and B*17 [<xref rid="B12-viruses-16-01839" ref-type="bibr">12</xref>]. While most of these studies are based on analysis of CD8<sup>+</sup> T cells isolated from peripheral blood, CD8<sup>+</sup> T cells exhibit tissue-specific viral control mechanisms [<xref rid="B13-viruses-16-01839" ref-type="bibr">13</xref>]. Tissue-resident CD8<sup>+</sup> T cells in lymphoid tissue and gastrointestinal mucosa are phenotypically and functionally distinct from peripheral blood CD8<sup>+</sup> T cells as they, unlike blood-derived CD8<sup>+</sup> T cells, can contribute to the control of viral infection via non-cytolytic mechanisms in addition to cytolytic mechanisms [<xref rid="B14-viruses-16-01839" ref-type="bibr">14</xref>,<xref rid="B15-viruses-16-01839" ref-type="bibr">15</xref>,<xref rid="B16-viruses-16-01839" ref-type="bibr">16</xref>,<xref rid="B17-viruses-16-01839" ref-type="bibr">17</xref>,<xref rid="B18-viruses-16-01839" ref-type="bibr">18</xref>]. Immunomodulatory cytokines such as interferon gamma (IFN&#x003b3;), interleukin-2 (IL-2), and tumor necrosis factor alpha (TNF&#x003b1;) modulate the overall quality of T cell responses during HIV/SIV infection. These cytokines regulate T cell proliferation, survival, antiviral and cytolytic functions among other supporting roles for CD4<sup>+</sup> and CD8<sup>+</sup> T cells [<xref rid="B19-viruses-16-01839" ref-type="bibr">19</xref>]. However, persistent antigen exposure and heightened immune activation during HIV/SIV infection results in progressive loss of function and proliferative capacity of CD8<sup>+</sup> T cells leading to a pool of exhausted CD8<sup>+</sup> T cells during chronic infection across all tissue sites [<xref rid="B20-viruses-16-01839" ref-type="bibr">20</xref>,<xref rid="B21-viruses-16-01839" ref-type="bibr">21</xref>].</p><p>While CD8<sup>+</sup> T cell-mediated viral control of HIV has been well studied in adults, our understanding of the underlying mechanisms by which it does so in pediatric HIV infection, particularly in difficult-to-access tissue sites of viral replication, such as gut and lymph nodes, is severely limited. Dynamic changes in the developing immune system continue into the post-natal period in infants where the immune cells are qualitatively and quantitatively different from adults [<xref rid="B22-viruses-16-01839" ref-type="bibr">22</xref>,<xref rid="B23-viruses-16-01839" ref-type="bibr">23</xref>,<xref rid="B24-viruses-16-01839" ref-type="bibr">24</xref>,<xref rid="B25-viruses-16-01839" ref-type="bibr">25</xref>]. Infants with HIV often have persistent high levels of viremia with elevated CD8<sup>+</sup> T cell activation in the chronic phase of infection compared with adults despite comparable levels of CD8<sup>+</sup> T cell proliferation early during infection as measured in blood [<xref rid="B26-viruses-16-01839" ref-type="bibr">26</xref>,<xref rid="B27-viruses-16-01839" ref-type="bibr">27</xref>]. The lack of CTL escape mutants in circulating virus in children reflects the weaker immunological selection pressure exerted by virus-specific CD8<sup>+</sup> T cells compared to adults, even when the CTL responses are restricted by protective MHC alleles such as HLA-B*57 [<xref rid="B28-viruses-16-01839" ref-type="bibr">28</xref>,<xref rid="B29-viruses-16-01839" ref-type="bibr">29</xref>]. Immature adaptive immune responses in infants and key differences in HIV/SIV pathogenesis compared to adults necessitate the elucidation of molecular mechanisms regulating CD8<sup>+</sup> T cell responses across different tissue sites during pediatric HIV/SIV infection.</p><p>Epigenetic modifications including DNA methylation regulate CD8<sup>+</sup> T cell differentiation, effector cell expansion, effector function, and exhaustion in lentiviral infections [<xref rid="B30-viruses-16-01839" ref-type="bibr">30</xref>,<xref rid="B31-viruses-16-01839" ref-type="bibr">31</xref>,<xref rid="B32-viruses-16-01839" ref-type="bibr">32</xref>,<xref rid="B33-viruses-16-01839" ref-type="bibr">33</xref>,<xref rid="B34-viruses-16-01839" ref-type="bibr">34</xref>,<xref rid="B35-viruses-16-01839" ref-type="bibr">35</xref>]. DNA methylation is a reversible epigenetic modification where a methyl group is added to the 5&#x02032;-C of the cytosine residue in the context of CG, CHH, or CHG within a DNA sequence by DNA methyltransferases [<xref rid="B36-viruses-16-01839" ref-type="bibr">36</xref>]. Changes in CpG methylation levels directly impact gene transcription. An increase in CpG DNA methylation at a gene promoter region results in gene repression, while a demethylated promoter is indicative of active gene expression [<xref rid="B36-viruses-16-01839" ref-type="bibr">36</xref>]. In adult chronic HIV infection, hypomethylation at the Programmed Death 1 (PD1) promoter has been associated with a concomitant increase in PD1 protein expression in virus-specific compared to na&#x000ef;ve CD8<sup>+</sup> T cells, suggesting a role for DNA methylation in CD8<sup>+</sup> T cell exhaustion [<xref rid="B35-viruses-16-01839" ref-type="bibr">35</xref>]. However, in pediatric HIV/SIV infection, DNA methylation changes mediating CD8<sup>+</sup> T cell regulation at different tissue sites remain unexplored.</p><p>As a first step towards understanding the mechanism of DNA methylation-based regulation of CD8<sup>+</sup> T cells during pediatric HIV/SIV infection in both blood and tissues, in this study, we utilized specimens from SIV<sub>mac239/251</sub> infected infant rhesus macaques to characterize tissue-specific CpG methylation signatures at the IFN&#x003b3;, IL-2, and TNF&#x003b1; promoters in CD8<sup>+</sup> T cells during chronic phase of pediatric SIV infection. We performed a systematic assessment of the methylation status of CD8<sup>+</sup> T cells from peripheral blood, lymph nodes, and intestinal tissues at the global DNA, cytokine promoter-wide, and CpG site-specific level in infant rhesus macaques to identify differentially methylated CpG sites during SIV infection. Our study represents the first known methylation analysis of CD8<sup>+</sup> T cells isolated from often inaccessible tissues such as lymph nodes and gut from infant rhesus macaques during SIV infection. The results from this study may inform a detailed investigation of the role of DNA methylation in modulating CD8<sup>+</sup> T cell effector responses at various tissue sites during pediatric HIV/SIV infection.</p></sec><sec sec-type="methods" id="sec2-viruses-16-01839"><title>2. Methods</title><p><bold>Animals, sample collection, and processing:</bold> This study was conducted with archived, cryopreserved peripheral blood mononuclear cells (PBMCs) or mononuclear cell suspensions (MNCs) from axillary/inguinal/mesenteric lymph nodes (LNs), or intestinal (ileum/ colon) tissues of SIV-infected infant rhesus macaques included in prior studies [<xref rid="B37-viruses-16-01839" ref-type="bibr">37</xref>,<xref rid="B38-viruses-16-01839" ref-type="bibr">38</xref>,<xref rid="B39-viruses-16-01839" ref-type="bibr">39</xref>]. At the time of those studies, all animals were nursery-reared and pair-housed at the UC Davis California National Primate Research Center. Study protocols and sample collections had been approved by the UC Davis Animal Care and Use Committee and were conducted in adherence to the guidelines of the Guide for the Care and Use of Laboratory Animals (<italic toggle="yes">National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC, USA</italic>). Age, SIV status, and SIV plasma viremia of rhesus macaques from which samples were obtained are listed in <xref rid="viruses-16-01839-t001" ref-type="table">Table 1</xref>.</p><p><bold>Cell stimulation and CD8<sup>+</sup> T cell isolation:</bold> Freshly thawed PBMCs or tissue MNCs were resuspended at 1.5 &#x000d7; 10<sup>6</sup> cells/mL of RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 1% penicillin-streptomycin, and 1% L-glutamine. Cells were stimulated with 5 &#x003bc;g/mL of concanavalin A (Con A) (Sigma, St. Louis, MO, USA) at 37 &#x000b0;C for 2 h to promote non-antigen-specific proliferation and cytokine production [<xref rid="B40-viruses-16-01839" ref-type="bibr">40</xref>]. Stimulated cells were washed with PBS (Gibco, Gaithersburg, MD, USA) at 500&#x000d7; <italic toggle="yes">g</italic> for 7 min and resuspended at 10<sup>7</sup> cells/mL in PBS+ 2% FBS (Serum Source International, Charlotte, NC, USA) + 1 mM EDTA (Thermo Fisher Scientific, Waltham, MA, USA). CD8<sup>+</sup> T cells were isolated using a custom-made Easy Sep&#x02122; Negative-Selection NHP CD8<sup>+</sup> T cell isolation kit with D-magnetic beads (Stem Cell, Vancouver, BC, USA). In brief, 52 &#x003bc;l/mL of CD8<sup>+</sup> T cell negative selection antibody cocktail and 50 &#x003bc;l/mL of &#x003b3;&#x003b4;-CD8<sup>+</sup> T cell-depletion antibody were added to 10<sup>7</sup> cells and incubated for 10 min at RT with constant shaking. Magnetic beads in suspension at 150 &#x003bc;l/mL of cells were added and incubated at RT for 5 min. CD8<sup>+</sup> T cells were then negatively selected according to the StemCell protocol; this step was repeated twice to ensure maximum recovery. The purity of CD8<sup>+</sup> T cells, as determined by flow cytometry, was &#x0003e;92% and the cell viability was &#x0003e;90% (See <xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material S1</xref>).</p><p><bold>DNA extraction and global methylation ELISA:</bold> Genomic DNA was extracted from Con A stimulated PBMCs and tissue-derived CD8<sup>+</sup> T cells using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) and quantified using a NanoDrop Lite Spectrophotometer (Thermo Scientific, Waltham, MA, USA). Global DNA methylation was measured using the MethylFlash Global DNA Methylation 5-mc ELISA kit (Epigentek, Farmingdale, NY, USA) according to the manufacturer&#x02019;s instructions. This kit allows for colorimetric quantification of global DNA methylation by specifically measuring 5-methylcytosine (5-mc) levels in input genomic DNA.</p><p>
<bold>Targeted Bisulfite Sequencing of Cytokine Promoter Regions</bold>
</p><p><italic toggle="yes">PCR amplification of bisulfite reduced genomic DNA:</italic> Genomic DNA (input: 250 ng) isolated from PBMCs and tissue-derived CD8<sup>+</sup> T cells was bisulfite converted using the EZ DNA Methylation-Gold Kit (Zymo Research, Irvine, CA, USA). Primers for bisulfite-reduced targets within the rhesus macaque IL-2, IFN&#x003b3;, and TNF&#x003b1; promoter regions were designed using the Zymo Research Bisulfite Primer Seeker (Zymo Research) as listed in <xref rid="viruses-16-01839-t002" ref-type="table">Table 2</xref> (<xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material S2</xref>). These selected regions of cytokine promoters had multiple predicted transcription factor binding sites as determined by the web-based tool PROMO which uses the transcription factor binding site database TRANSFAC version 6.4 for its predictions [<xref rid="B41-viruses-16-01839" ref-type="bibr">41</xref>,<xref rid="B42-viruses-16-01839" ref-type="bibr">42</xref>]. The PCR reaction cocktail consisted of 5 &#x000b5;L of template DNA, 12.5 &#x000b5;L KAPA HiFi Uracil + Readymix (Kapa Biosystems, Wilmington, MA, USA), 0.4 &#x000b5;M (1 &#x000b5;L) forward primer, 0.4 &#x000b5;M (1 &#x000b5;L) reverse primer and 5.5 &#x000b5;L of nuclease-free water. PCR amplification was conducted under the following cycling conditions: hot start enzyme activation at 95 &#x000b0;C for 5 min, 40 cycles of denaturation at 98 &#x000b0;C for 20 s, annealing at 60 &#x000b0;C for 15 s, and 72 &#x000b0;C for 1 min, followed by 72 &#x000b0;C for 1 min and a final 4 &#x000b0;C hold step. PCR products were sequenced to confirm the promoter sequences (Genewiz, Germantown, MD, USA).</p><p><italic toggle="yes">Library preparation and sequencing:</italic> Libraries of the promoter amplicons were prepared using the Nextera XT DNA Library Prep Kit and Nextera XT Index Kit (Illumina Inc., San Diego, CA, USA; protocol February 2018, v03). DNA was quantified on a Qubit<sup>&#x000ae;</sup> 3.0 Fluorometer using a Qubit dsDNA High Sensitivity Kit (Life Technologies, Carlsbad, CA, USA). Briefly, 5 &#x000b5;L of DNA (at a concentration of 0.2 ng/&#x000b5;L) was fragmented using 5 &#x000b5;L Amplicon Tagment Mix with 10 &#x000b5;L of Tagment DNA buffer (Illumina Inc.). Tagmentation reactions were performed by incubation at 55 &#x000b0;C for 5 min followed by the addition of 5 &#x000b5;L Neutralize Tagment Buffer. The tagmented DNA (25 &#x000b5;L) was used as the template in a 50 &#x000b5;L adapter ligating PCR (15 cycles). Amplified DNA was purified using 1.8&#x000d7; of the volume of AMPure XP beads (Beckman Coulter Inc., Brea, CA, USA). The fragment size distribution of the tagmented and adapter-ligated DNA was analyzed utilizing an Experion&#x02122; Automated Electrophoresis System (Bio-Rad, Hercules, CA, USA). Barcoded DNA libraries were pooled and sequenced using a paired-end, 2 &#x000d7; 150 read length MiSeq platform at the High Throughput Sequencing Facility (HTSF) Core at the University of North Carolina at Chapel Hill. Raw reads were re-allocated to each DNA sample&#x02019;s unique Nextera barcode during analysis. </p><p><italic toggle="yes">CpG methylation analysis:</italic> Fastq files from HTSF were analyzed using the CLC Genome Workbench software (version 11, CLC Bio, Qiagen). Files were first merged for forward and reverse reads to the appropriate barcoded samples. Paired PBMC reads were individually aligned to reference sequences acquired from the NCBI database (<xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material S2</xref>). The reference sequences were bisulfite-converted by the CLC Genome Workbench program. Reads from tissue CD8<sup>+</sup> T cells were grouped by SIV status, creating a consensus sequence that represented the alignment of all reads selected against the specified reference gene sequence based on the chosen mapping parameters (non-directional, 0.8 similarity fraction, non-specific matches mapped randomly). The resulting sequences were then used to determine the percent CpG methylation of the experimental sample compared to the reference sequence. DNA methylation was assessed across the whole amplicon and at specific CpG sites within the amplicon.</p><p><bold>Statistical analysis:</bold> Statistical analysis was performed using GraphPad Prism software version 10.0. Paired PBMC samples were compared using a two-tailed paired <italic toggle="yes">t</italic>-test while the unpaired tissue sample data were compared using the Mann&#x02013;Whitney test. <italic toggle="yes">p</italic> values of <italic toggle="yes">p</italic> &#x0003c; 0.05 were considered statistically significant. </p></sec><sec sec-type="results" id="sec3-viruses-16-01839"><title>3. Results</title><sec id="sec3dot1-viruses-16-01839"><title>3.1. Genomic DNA Methylation in PBMC, Lymph Node, and Intestinal CD8<sup>+</sup> T Cells During SIV Infection</title><p>The overall degree of genomic DNA methylation provides insight into the global epigenetic regulatory status of cells of interest [<xref rid="B43-viruses-16-01839" ref-type="bibr">43</xref>]. Therefore, we first quantitated the levels of 5-methylcytosine (5-mc) in genomic DNA from bulk CD8<sup>+</sup> T cells isolated from peripheral blood (PBMCs) and from mononuclear cell suspensions derived from lymph nodes and intestine. Measured global DNA methylation levels were higher in PBMC-derived CD8<sup>+</sup> T cells collected following SIV infection compared with matched pre-infection samples collected from the same four animals (<xref rid="viruses-16-01839-f001" ref-type="fig">Figure 1</xref>A).</p><p>Unlike the PBMC samples, longitudinal pre- and post-infection samples for lymph node and intestinal tissue from the same animals were not available. Instead, we compared paired lymph node and intestinal CD8<sup>+</sup> T cells from four SIV-na&#x000ef;ve animals with three SIV-infected animals for tissue-specific assays as listed in <xref rid="viruses-16-01839-t001" ref-type="table">Table 1</xref>. Mean global DNA methylation percentages were higher in both lymph node (7.4%) and intestinal (11.9%) CD8<sup>+</sup> T cells in the three SIV-infected animals compared to CD8<sup>+</sup> T cells of lymph nodes (5.9%) and intestinal tissues (8.0%) of SIV-na&#x000ef;ve animals, but the differences were not statistically significant (<xref rid="viruses-16-01839-f001" ref-type="fig">Figure 1</xref>B). However, within the SIV-na&#x000ef;ve group, there was a trend towards higher baseline global DNA methylation levels in the intestinal compared to lymph node CD8<sup>+</sup> T cells, and a similar difference was observed within the SIV-infected group (<xref rid="viruses-16-01839-f001" ref-type="fig">Figure 1</xref>B). Overall, despite the lack of statistical significance in this comparison between limited numbers of tissue samples, these data suggest that global DNA methylation levels in SIV-infected versus uninfected infant rhesus macaque CD8<sup>+</sup> T cells may vary across different anatomical compartments.</p></sec><sec id="sec3dot2-viruses-16-01839"><title>3.2. Methylation of the IFN&#x003b3;, IL-2, and TNF&#x003b1; Cytokine Promoters in CD8<sup>+</sup> T Cells of SIV-Na&#x000ef;ve and SIV-Infected Infant Rhesus Macaques</title><p>IFN&#x003b3;, IL-2, and TNF&#x003b1; are essential cytokines for CD8<sup>+</sup> T cell function and immune regulation during SIV infection [<xref rid="B44-viruses-16-01839" ref-type="bibr">44</xref>,<xref rid="B45-viruses-16-01839" ref-type="bibr">45</xref>]. We next analyzed DNA methylation patterns at the promoters of these immunomodulatory cytokines in CD8<sup>+</sup> T cells during SIV infection in infant macaques. CpG dinucleotides prone to methylation changes are clustered in CpG islands (CGI), which are enriched in gene promoters and overlap with transcription start sites (TSS) [<xref rid="B46-viruses-16-01839" ref-type="bibr">46</xref>]. Hypermethylation of the CGIs is frequently associated with transcriptional repression [<xref rid="B43-viruses-16-01839" ref-type="bibr">43</xref>]. Therefore, we quantitated promoter-wide methylation changes in regions up to 1000 bp upstream of the TSS for IFN&#x003b3;, IL-2, and TNF&#x003b1; (<xref rid="viruses-16-01839-t003" ref-type="table">Table 3</xref>). These regions of cytokine promoters were selected because they are enriched in multiple predicted transcription factor binding sites critical for downstream gene regulation (<xref rid="viruses-16-01839-t004" ref-type="table">Table 4</xref>).</p><p><xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref> shows the cytokine promoter-wide methylation changes recorded in PBMC-derived CD8<sup>+</sup> T cells during SIV infection compared to prior to infection. Methylation at the IFN&#x003b3; promoter declined (<italic toggle="yes">p</italic> = 0.0118) in all 4 animals post- compared with pre-infection (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>A). At the IL-2 promoter, methylation levels decreased in 3 of 4 animals post-SIV infection compared with pre-infection, although this difference was not significant (<italic toggle="yes">p</italic> = 0.1133) likely because methylation levels remained unchanged in 1 of 4 animals (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>B). In contrast, at the TNF&#x003b1; promoter, there was a trend towards increased methylation post- compared to pre-infection (<italic toggle="yes">p</italic> = 0.0942); however, this increase was only observed in 3 of 4 animals while the levels decreased in 1 of 4 animals post- compared with pre-infection (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>C). The hypomethylated state of the IFN&#x003b3; and IL-2 promoters in 4 of 4 and 3 of 4 animals, respectively, post-SIV infection compared to pre-infection in PBMC-derived CD8<sup>+</sup> T cells indicated active gene transcription based on the known dogma of permissiveness of hypomethylated promoter for downstream gene activation, whereas the increase in methylation at the TNF&#x003b1; promoter in 3 of 4 animals post-infection was expected to be associated with repression of gene transcription compared to pre-infection. These data suggested differential regulation of distinct cytokine promoters in peripheral blood CD8<sup>+</sup> T cells during SIV infection, encouraging us to perform a more specific and nuanced, base-level methylation change comparison.</p><p>Unlike the changes observed at each cytokine promoter in PBMC-derived CD8<sup>+</sup> T cells, there were no differences between SIV-infected and SIV-uninfected animals in the measured methylation levels at the cytokine promoters in CD8<sup>+</sup> T cells derived from lymph node or intestinal tissues (<xref rid="viruses-16-01839-t005" ref-type="table">Table 5</xref>, <xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>).</p><p>However, the cytokine promoters in CD8<sup>+</sup> T cells were differentially methylated across the two tissues, lymph node, and intestine, within the same animal. In SIV-uninfected animals, differences in methylation were observed for the IL-2 and the TNF&#x003b1; promoters. The IL-2 promoter of SIV-uninfected animals was hypomethylated in intestinal (Mean% &#x000b1; standard deviation: 65.4% &#x000b1; 8.1) compared to lymph node (82.7% &#x000b1; 6.3) derived CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>B). Although there was a trend towards reduced mean methylation in the IFN&#x003b3; promoter of intestinal CD8<sup>+</sup> T cells (71.0% &#x000b1; 3.1) versus lymph node CD8<sup>+</sup> T cells (79.5% &#x000b1; 9.0), this difference was not significant as one animal (upwards triangle symbol) had higher methylation at the intestinal compared to the lymph node site (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>A). In contrast, the TNF&#x003b1; promoter exhibited higher methylation in the intestinal (47.0% &#x000b1; 2.6) compared to the lymph node (39.8% &#x000b1; 6.1) CD8<sup>+</sup> T cells in the same animal (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>C). In SIV-infected animals, both the IFN&#x003b3; and IL-2 promoters had lower methylation in the intestinal (IFN&#x003b3;: 69.1% &#x000b1; 4.9; IL-2: 67.4% &#x000b1; 1.7) compared to the lymph node (IFN&#x003b3;: 78.8% &#x000b1; 4.8, IL-2: 82.7% &#x000b1; 1.0) CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>A,B). A trend towards higher CpG methylation in the TNF&#x003b1; promoter of intestinal CD8<sup>+</sup> T cells (53.9% &#x000b1; 1.1) versus lymph node CD8<sup>+</sup> T cells (45.0% &#x000b1; 10.9) in SIV-infected animals was observed, however, was not significant (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>C).</p></sec><sec id="sec3dot3-viruses-16-01839"><title>3.3. CpG Site-Specific Methylation at CD8<sup>+</sup> T Cell Cytokine Promoters of Different Tissues in SIV-Infected Compared to Uninfected Infant Rhesus Macaques</title><p>After quantitating the overall methylation status of cytokine promoters, we sought to evaluate methylation signatures at specific CpG sites within these promoters across different tissue samples during SIV infection. The region of interest for the IFN&#x003b3; promoter had three CpG sites at positions 183, 315, and 410 base pairs upstream of the IFN&#x003b3; gene TSS as listed in <xref rid="viruses-16-01839-t003" ref-type="table">Table 3</xref> (<xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material S2</xref>). Methylation changes were only detected in the DNA-negative strand. A reduction in methylation was observed at all three sites in peripheral blood CD8<sup>+</sup> T cells in all four animals post- compared to pre-SIV infection (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>A). In lymph node and intestinal CD8<sup>+</sup> T cells, no difference was observed in CpG methylation at the IFN&#x003b3; promoter in SIV-infected compared to uninfected animals (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>B,C).</p><p>The IL-2 promoter region of interest had three CpG sites at 306, 644, and 702 base pairs upstream of the <italic toggle="yes">IL-2</italic> gene TSS as listed in <xref rid="viruses-16-01839-t003" ref-type="table">Table 3</xref> (<xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material S2</xref>). In peripheral blood, CD8<sup>+</sup> T cells, methylation decreased at position &#x02212;306 in 3 of 4 animals and at positions &#x02212;702 and &#x02212;644 in 4 of 4 infant rhesus macaques post-SIV infection compared to pre-infection, although the reduction was only significant at position &#x02212;702 (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>D). In lymph node-derived CD8<sup>+</sup> T cells, no methylation differences were observed at any of the CpG sites in SIV-infected versus uninfected animals (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>E). Methylation was lower, however, at one of the three CpG sites, site &#x02212;644, in the IL-2 promoter of intestinal CD8<sup>+</sup> T cells of SIV-infected animals compared to SIV-na&#x000ef;ve animals (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>F).</p><p>The TNF&#x003b1; promoter region assessed in this study contained 11 CpG sites as listed in <xref rid="viruses-16-01839-t003" ref-type="table">Table 3</xref> (<xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material S2</xref>). At 5 of 11 sites (positions, &#x02212;172, &#x02212;220, &#x02212;251, &#x02212;340, and &#x02212;342), there was an increase in methylation after SIV infection compared to prior to infection in peripheral blood CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f005" ref-type="fig">Figure 5</xref>A). SIV-infected animals had high animal-to-animal variability in the methylation levels at specific CpG sites of the TNF&#x003b1; promoter in lymph node and intestinal CD8<sup>+</sup> T cells. While 2 of 3 SIV-infected animals had higher methylation at sites &#x02212;172, &#x02212;220, &#x02212;228, &#x02212;251, and &#x02212;298 of the TNF&#x003b1; promoter in lymph node CD8<sup>+</sup> T cells compared to the 4 SIV-na&#x000ef;ve animals, methylation in the 3rd SIV-infected animal was relatively low and comparable to SIV-na&#x000ef;ve animals (<xref rid="viruses-16-01839-f005" ref-type="fig">Figure 5</xref>B). In intestinal CD8<sup>+</sup> T cells, however, some of the same CpG sites exhibited reduced methylation in SIV-infected compared to SIV-na&#x000ef;ve animals (<xref rid="viruses-16-01839-f005" ref-type="fig">Figure 5</xref>C). Overall, though, SIV status did not significantly affect site-specific TNF&#x003b1; promoter methylation in lymph node or intestinal CD8<sup>+</sup> T cells.</p></sec><sec id="sec3dot4-viruses-16-01839"><title>3.4. Differences in CpG Site-Specific Methylation Patterns at Each Cytokine Promoter in Lymph Node and Intestinal Tissue CD8<sup>+</sup> T Cells</title><p>Because we had observed differences in cytokine promoter-wide methylation between CD8<sup>+</sup> T cells isolated from lymph nodes or intestinal tissues of the same animal, we also tested for tissue-specific methylation differences at specific CpG sites for each cytokine promoter within the same animal in both SIV uninfected and infected groups. There was a trend towards lower CpG methylation in intestinal compared to lymph node CD8<sup>+</sup> T cells from both SIV-na&#x000ef;ve and SIV-infected animals at all three sites in the IFN&#x003b3; and IL-2 promoters (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>A&#x02013;D). Methylation was significantly lower in intestinal compared to lymph node CD8<sup>+</sup> T cells of SIV-na&#x000ef;ve animals at CpG sites &#x02212;183 and &#x02212;315 at the IFN&#x003b3; promoter (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>A). While the difference in methylation at CpG site &#x02212;183 was also observed in SIV-infected animals, differences at site &#x02212;315 were diminished, and in addition, site &#x02212;410 exhibited lower methylation in intestinal compared to lymph node CD8<sup>+</sup> T cells of SIV-infected animals (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>B). In the IL-2 promoter, the difference was significant for the &#x02212;644 site in both SIV-na&#x000ef;ve and infected animals (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>C,D). In the TNF&#x003b1; promoter, 9 of 11 CpG sites trended towards equal or lower methylation in intestinal compared to lymph node CD8<sup>+</sup> T cells of SIV-na&#x000ef;ve animals, but CpG sites &#x02212;340 and &#x02212;348 exhibited an opposite trend with higher methylation in intestinal versus lymph node CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>E). In SIV-infected animals, methylation at site &#x02212;340 was significantly higher in intestinal compared to lymph node CD8<sup>+</sup> T cells, and a trend towards higher methylation in intestinal CD8<sup>+</sup> T cells was also observed at sites &#x02212;342 and &#x02212;348 (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>F).</p><p>Overall, both promoter-wide and CpG-site specific methylation in CD8<sup>+</sup> T cells of SIV-na&#x000ef;ve animals were higher at the IFN&#x003b3; and IL-2 promoter compared to the TNF&#x003b1; promoter at all tissue sites. During SIV infection, promoter-wide and CpG-site specific methylation decreased at the IFN&#x003b3; and IL-2 promoters but increased at the TNF&#x003b1; promoter in peripheral blood CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>, <xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>A,D and <xref rid="viruses-16-01839-f005" ref-type="fig">Figure 5</xref>A). Independent of SIV status, promoter-wide and site-specific CpG methylation at the IFN&#x003b3; and IL-2 promoters trend higher in lymph node compared to intestinal CD8<sup>+</sup> T cells, whereas distinct CpG sites within the TNF&#x003b1; promoter may express higher or lower relative methylation in lymph node versus intestinal CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref> and <xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-viruses-16-01839"><title>4. Discussion</title><p>CD8<sup>+</sup> T cells are key players in the control of HIV/SIV infection. However, persistently high levels of antigen exposure during untreated chronic HIV infection leads to the progressive loss of CD8<sup>+</sup> T cell function [<xref rid="B8-viruses-16-01839" ref-type="bibr">8</xref>,<xref rid="B27-viruses-16-01839" ref-type="bibr">27</xref>], motivating an effort to define molecular mechanisms regulating CD8<sup>+</sup> T cell responses within various tissues, particularly in the setting of understudied pediatric HIV/SIV infection. In young infants that acquire HIV perinatally or by breastfeeding, CD8<sup>+</sup> T cell function may further be impacted by dynamic post-natal development processes involving immune system cells [<xref rid="B22-viruses-16-01839" ref-type="bibr">22</xref>]. Mechanisms regulating CD8<sup>+</sup> T cell responses are poorly understood in pediatric infections, in part due to the strikingly low number of pediatric or adolescent population-specific studies [<xref rid="B47-viruses-16-01839" ref-type="bibr">47</xref>] and small sample volumes that limit the extent and diversity of analyses that can be performed on the available samples.</p><p>The current study is a first step towards defining the role of DNA methylation, an epigenetic modification regulating gene expression, in the regulation of CD8<sup>+</sup> T cells in various anatomic compartments during pediatric AIDS virus infection. Utilizing the infant rhesus macaque SIV<sub>mac239/251</sub> infection model, we describe the tissue-specific methylation signatures of CD8<sup>+</sup> T cells during chronic SIV infection by performing a stepwise methylation analysis of total genomic DNA, immunomodulatory cytokine promoters, and CpG sites within those cytokine promoters across peripheral blood, lymph nodes, and intestinal tissue. We focused our analysis on the modulation of IFN&#x003b3;, IL-2, and TNF&#x003b1; cytokine promoters as the autocrine effect of these cytokines is one of the mechanisms required for modulating proliferation and antiviral function of CD8<sup>+</sup> T cells in response to HIV/SIV infection [<xref rid="B8-viruses-16-01839" ref-type="bibr">8</xref>,<xref rid="B48-viruses-16-01839" ref-type="bibr">48</xref>].</p><p>Among the cytokine promoters evaluated, the most substantial methylation differences at each tissue site during SIV infection compared to infection-na&#x000ef;ve animals were observed at the IFN&#x003b3; promoter of CD8<sup>+</sup> T cells. The higher permissiveness of the IFN&#x003b3; promoter for active gene expression inferred by the hypomethylation observed in PBMC CD8<sup>+</sup> T cells post-SIV infection compared to pre-infection (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>A) and intestinal compared to lymph node CD8<sup>+</sup> T cells in SIV-infected animals (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>A) likely represents one of the mechanisms underlying the higher IFN&#x003b3; mRNA [<xref rid="B49-viruses-16-01839" ref-type="bibr">49</xref>] and cytokine levels in plasma that have been described during HIV-1 infection [<xref rid="B50-viruses-16-01839" ref-type="bibr">50</xref>,<xref rid="B51-viruses-16-01839" ref-type="bibr">51</xref>]. Site-specific methylation assessment of CpG sites within the IFN&#x003b3; promoter provided a more detailed picture of methylation alterations in CD8<sup>+</sup> T cells from different tissues during SIV infection. The reduction in methylation at all 3 CpG sites post-SIV-infection compared to pre-infection in PBMC CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>A) and the hypomethylation of site &#x02212;410 in SIV-infected animals exclusively in intestinal compared to lymph node CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>B) suggest that these alterations are induced by SIV infection. The DNA sequence containing these differentially methylated CpG sites included the predicted binding sites for various transcription factors involved in T cell activation and transcriptional regulation such as Nuclear Factor of Activated T cells-1 (NFAT-1), NFAT-2, T-cell Factor (TCF) isoforms, Lymphoid Enhancer Factor (LEF-1), and NF-KB (Nuclear Factor-kappa B) (<xref rid="viruses-16-01839-t004" ref-type="table">Table 4</xref>). It is likely that CpG site &#x02212;410, which coincides with the predicted binding site for NFAT-1, NFAT-2, c-Ets-1, and NF-KB (<xref rid="viruses-16-01839-t004" ref-type="table">Table 4</xref>) plays an important functional and regulatory role in IFN&#x003b3; gene expression during SIV infection in PBMCs and intestinal tissues, although this would need to be tested further.</p><p>In contrast to the IFN&#x003b3; promoter, we did not measure substantial methylation alterations at the IL-2 promoter associated with SIV infection. Studies utilizing the Jurkat T cell line and murine CD4<sup>+</sup> T cells have shown that the IL-2 promoter and enhancer region is prone to methylation changes in response to stimulation, with methylation changes in a small region of the IL-2 promoter associated with measurable transcriptional changes [<xref rid="B52-viruses-16-01839" ref-type="bibr">52</xref>,<xref rid="B53-viruses-16-01839" ref-type="bibr">53</xref>,<xref rid="B54-viruses-16-01839" ref-type="bibr">54</xref>]. Previous studies have also shown that stimulation-driven methylation changes in CpG sites proximal to TSS have a direct impact on <italic toggle="yes">IL-2</italic> gene transcription levels in murine and human cord blood CD4<sup>+</sup> T cells [<xref rid="B53-viruses-16-01839" ref-type="bibr">53</xref>]. In our study, we therefore evaluated methylation changes in a region within the IL-2 promoter immediately proximal, up to 600 bp upstream, of the TSS. Though we did not observe significant methylation changes at the IL-2 promoter in PBMC CD8<sup>+</sup> T cells post-SIV infection compared to pre-infection (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>B and found lower methylation in intestinal CD8<sup>+</sup> T cells compared to lymph nodes in both SIV-na&#x000ef;ve and infected animals (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>B), it remains possible that the promoter region critical for IL-2 transcriptional control during SIV infection may be different in infant rhesus macaques from the one assessed in our study, which was based on the results of previous human and murine studies. Other regions of the IL-2 promoter and IL-2 regulatory regions need to be examined to conclusively evaluate whether methylation changes occur at the IL-2 promoter in response to SIV infection in infant macaques. However, the selected IL-2 promoter region contains predicted binding sites for multiple inducible and constitutive transcription factors, including NFAT1/2 that are regulated based on cell activation status and TCF, Oct-1, and forkhead box protein P3 (Foxp3) that are constitutively expressed (<xref rid="viruses-16-01839-t004" ref-type="table">Table 4</xref>). CpG site &#x02212;702, a predicted Foxp3 binding site, showed reduced methylation in all animals post-infection versus pre-infection in PBMC-CD8<sup>+</sup> T cells (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>D), while CpG site &#x02212;644, a predicted C/EBP&#x003b2; binding site, was hypomethylated in intestinal CD8<sup>+</sup> T cells in SIV-infected animals compared to SIV-uninfected animals (<xref rid="viruses-16-01839-f004" ref-type="fig">Figure 4</xref>F). The proximity of these differentially methylated CpG sites to key regulatory transcription factor binding sites suggests they may be essential for IL-2 transcriptional regulation. The demethylation of CpG site &#x02212;702 post-SIV-infection versus pre-infection at the IL-2 promoter in PBMC&#x02014;CD8<sup>+</sup> T cells was in contrast with a previous report where none of the IL-2 promoter CpG sites were differentially methylated in PBMC- CD8<sup>+</sup> T cells in HIV-1 non-controllers compared to controllers and uninfected individuals [<xref rid="B55-viruses-16-01839" ref-type="bibr">55</xref>]. This discrepancy could reflect differences in CD8<sup>+</sup> T cell regulation by SIV versus HIV-1, the differences in host species, differential modulation of CD8<sup>+</sup> T cells in infants versus adults, or a combination of all three.</p><p>DNA methylation patterns at the TNF&#x003b1; promoter during SIV infection differed from the IL-2 and IFN&#x003b3; promoters. At the TNF&#x003b1; promoter, we observed a trend towards increased promoter-wide methylation in PBMC CD8<sup>+</sup> T cells post-SIV infection compared to pre-infection (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>C) and a trend towards higher methylation in both intestinal and lymph node CD8<sup>+</sup> T cells in SIV-infected compared to uninfected animals (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>C), suggestive of gene repression during chronic SIV infection. Five of 11 CpG sites assessed in the TNF&#x003b1; promoter were hypermethylated in PBMC CD8<sup>+</sup> T cells post-SIV infection compared to pre-infection (<xref rid="viruses-16-01839-f005" ref-type="fig">Figure 5</xref>A), of which only 1 CpG site at position -340 was significantly hypermethylated in intestinal compared to lymph node CD8<sup>+</sup> T cells in SIV-infected animals (<xref rid="viruses-16-01839-f006" ref-type="fig">Figure 6</xref>F). These differentially methylated CpG sites coincided with key regulatory transcription factor binding sites such as C/EBP&#x003b2;, Foxp3, and YY1 (<xref rid="viruses-16-01839-t004" ref-type="table">Table 4</xref>) supporting their potential in TNF&#x003b1; regulation during SIV infection. The data show that the regulation of TNF&#x003b1; is different from IFN&#x003b3; and IL-2 likely due to its inhibitory and activation roles during HIV-1/SIV infection and its pleiotropic effects on various cell types [<xref rid="B56-viruses-16-01839" ref-type="bibr">56</xref>], whereas IFN&#x003b3; and IL-2 are classically associated with CD8<sup>+</sup> T cell effector function. One can speculate that the higher number of CpG sites in the selected region of TNF&#x003b1; promoter (11 sites) compared to three sites each in the IFN&#x003b3; and IL-2 promoters likely results in differential downstream gene regulation of TNF&#x003b1; compared to IFN&#x003b3; and IL-2, although this would require direct testing. Overall, our cytokine-specific data suggest that in CD8<sup>+</sup> T cells from chronic SIV<sub>mac239/251</sub> infection of infant rhesus macaques, IFN&#x003b3; and IL-2 promoters are poised for active transcription with lower methylation levels, which contrasts with the expectation from functionally dysregulated CD8<sup>+</sup> T cells associated with chronic SIV infection.</p><p>We also evaluated and compared tissue-specific methylation differences in CD8<sup>+</sup> T cells during chronic SIV infection. In addition to assessing peripheral blood-derived CD8<sup>+</sup> T cells, we also defined methylation signatures of CD8<sup>+</sup> T cells from key tissue sites of viral replication that are difficult to access in human pediatric studies. In peripheral blood, the data clearly indicated that global DNA methylation of CD8<sup>+</sup> T cells increased after SIV infection (<xref rid="viruses-16-01839-f001" ref-type="fig">Figure 1</xref>A). However, when we focused on specific cytokine promoters in PBMC-derived CD8<sup>+</sup> T cells, cytokine-specific differences emerged where there was a significant decrease in promoter methylation for the IFN&#x003b3; promoter, a trend towards decreasing methylation for the IL-2 promoter, but an increase in TNF&#x003b1; promoter methylation post SIV-infection compared to prior to infection (<xref rid="viruses-16-01839-f002" ref-type="fig">Figure 2</xref>). These trends were supported by the examination of methylation of the distinct CpG sites within each cytokine promoter. Our data were not in agreement with a study reported by Nakayama-Hosoya et al. where no difference was observed in the methylation levels of IL-2, IFN&#x003b3;, and TNF&#x003b1; promoters in PBMC-derived CD8<sup>+</sup> T cells isolated from HIV-1 non-controllers compared to controllers and uninfected individuals, perhaps due to species-specific and/or virus-specific differences between the two studies [<xref rid="B55-viruses-16-01839" ref-type="bibr">55</xref>]. It is also possible that the differences in methylation levels in PBMCs are more easily visualized when comparing longitudinal post versus pre-infection samples from the same animal as opposed to in a cross-sectional analysis as reported by Nakayama-Hosoya et al. Compared to peripheral blood, HIV/SIV viral burden and associated immunological features are different in lymph node and intestinal tissues [<xref rid="B15-viruses-16-01839" ref-type="bibr">15</xref>,<xref rid="B57-viruses-16-01839" ref-type="bibr">57</xref>]. As the main sites of viral replication, viral burden is higher in intestinal and lymph nodes harboring a higher number of viral RNA<sup>+</sup> T cells compared to peripheral blood [<xref rid="B58-viruses-16-01839" ref-type="bibr">58</xref>]. Our assessment of SIV infection-associated DNA methylation differences in CD8<sup>+</sup> T cells from lymph nodes and intestinal tissues compared to uninfected animals was less conclusive than the peripheral blood dataset likely due to the absence of longitudinal tissue samples post SIV- infection compared to prior to infection. Unlike the peripheral blood dataset, where we had paired samples for comparison, tissue CD8<sup>+</sup> T cells of 4 SIV-na&#x000ef;ve animals were compared to the same tissue type but obtained from 3 different SIV-infected animals. Therefore, while we also observed a trend towards higher global DNA methylation in lymph node and intestinal CD8<sup>+</sup> T cells from SIV-infected compared to SIV-na&#x000ef;ve animals, this difference did not reach statistical significance (<xref rid="viruses-16-01839-f001" ref-type="fig">Figure 1</xref>B). Similarly, we did not detect differences in promoter-wide methylation at the IFN&#x003b3;, IL-2 or TNF&#x003b1; promoters in tissue-derived CD8<sup>+</sup> T cells from SIV-infected compared to SIV-na&#x000ef;ve animals likely due to the limited sample size per group (<xref rid="viruses-16-01839-t005" ref-type="table">Table 5</xref>). Thus, in future studies, it will be essential to obtain longitudinal tissue biopsy samples from the same animal prior to infection and then post-infection or have a larger sample size per group for a well-powered cross-sectional study to assess the impact of epigenetic modifications on tissue CD8<sup>+</sup> T cells in response to SIV infection.</p><p>The tissue analysis, nonetheless, yielded important insights into the role of DNA methylation on CD8<sup>+</sup> T cell regulation across lymph nodes and intestine within the same animal in both SIV-uninfected and infected groups. Differences in viral burden and immune activation result in distinct immunological milieu in intestinal tissue compared to lymph nodes during HIV/SIV infection [<xref rid="B57-viruses-16-01839" ref-type="bibr">57</xref>,<xref rid="B59-viruses-16-01839" ref-type="bibr">59</xref>,<xref rid="B60-viruses-16-01839" ref-type="bibr">60</xref>,<xref rid="B61-viruses-16-01839" ref-type="bibr">61</xref>]. The impact of these factors was evident in the distinct methylation patterns observed in intestinal versus lymph node CD8<sup>+</sup> T cells, particularly at the IFN&#x003b3; promoter. At the promoter-wide level, methylation at the IFN&#x003b3; promoter was significantly lower in intestinal compared to lymph node CD8<sup>+</sup> T cells in SIV-infected animals, with a similar though non-significant trend observed in SIV uninfected animals (<xref rid="viruses-16-01839-f003" ref-type="fig">Figure 3</xref>A). However, the global DNA methylation levels of total cellular DNA indicated a trend towards an overall repressive state due to higher methylation of intestinal CD8<sup>+</sup> T cells compared to lymph nodes, independent of SIV status (<xref rid="viruses-16-01839-f001" ref-type="fig">Figure 1</xref>B). Multiple factors likely contribute to the overall higher methylation levels of intestinal CD8<sup>+</sup> T cell genomic DNA. Firstly, intestinal CD8<sup>+</sup> T cells in infants exhibit reduced functionality in the early immune development phases [<xref rid="B62-viruses-16-01839" ref-type="bibr">62</xref>], and secondly, CD8<sup>+</sup> T cells progressively become dysregulated due to higher immune activation in the gut [<xref rid="B57-viruses-16-01839" ref-type="bibr">57</xref>,<xref rid="B59-viruses-16-01839" ref-type="bibr">59</xref>]. In addition, it is important to note that our study assessed methylation signatures from bulk CD8<sup>+</sup> T cells where the relative proportion and contribution of various CD8<sup>+</sup> T cell subsets was not determined due to limited samples from infant macaques. Although not tested directly, the relative proportion of polyfunctional, non-recirculating, tissue-resident CD8<sup>+</sup> T cells and other circulating CD8<sup>+</sup> T cell subsets at each tissue would impact the methylation signature observed in our study [<xref rid="B58-viruses-16-01839" ref-type="bibr">58</xref>,<xref rid="B63-viruses-16-01839" ref-type="bibr">63</xref>,<xref rid="B64-viruses-16-01839" ref-type="bibr">64</xref>]. Our tissue analysis suggests that the DNA-methylation patterns in CD8<sup>+</sup> T cells are distinct for each cytokine at different anatomic locations in SIV-infected infant rhesus macaques likely impacted by varying levels of antigen exposure and cellular composition at each tissue site.</p><p>This study presents a systematic assessment and characterization of tissue-specific DNA methylation signatures of CD8<sup>+</sup> T cells both at the total cellular DNA level and at key immunomodulatory cytokines during pediatric SIV infection. This study leveraged unique samples from previously completed infant rhesus macaque studies to elucidate the epigenetic landscape of CD8<sup>+</sup> T cells across various anatomic sites during infection which is severely understudied in pediatric HIV infections. Despite the low sample numbers, to our knowledge, this is the first study to compare the methylation signature of CD8<sup>+</sup> T cells from lymph node versus intestinal tissue within the same animal in the infant SIVmac<sub>239/251</sub> infection model. However, we were unable to perform any additional correlative virologic, transcriptional, or functional assays due to limited sample availability from previously completed infant rhesus macaque studies utilized here. Further studies will be needed to investigate the transcriptional and functional impact of the DNA methylation patterns identified in this study, particularly the role of the differentially methylated CpG sites identified. Methods similar to those used here could be used to evaluate DNA methylation changes at additional immune response genes, including cytokines and chemokines essential for cytolytic activity of CD8<sup>+</sup> T cells, such as Granzyme B, Perforin, and MIP1&#x003b2;. Overall, this study highlights the importance of assessing cells from both blood and tissue compartments to fully understand the regulation of CD8<sup>+</sup> T cells and lays the foundation for new research avenues to determine the role of epigenetic modulation, specifically DNA methylation in the regulation of CD8<sup>+</sup> T cell responses during pediatric HIV infection.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the High-Throughput Sequencing Facility (HTSF) at University of North Carolina at Chapel Hill for their sequencing services, the CCR-Sequencing Facility Bioinformatics team at the National Cancer Institute (NCI), National Institutes of Health (NIH) for helpful discussions on methylation data analysis and the NCI-Scientific Publications, Graphics and Media (SPGM) team for generating the tables. We also thank Jeffrey Lifson (Frederick National Lab) for helpful discussions.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-viruses-16-01839"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/v16121839/s1">https://www.mdpi.com/article/10.3390/v16121839/s1</uri>. Supplementary Material S1: Representative flow cytometry plots showing CD8<sup>+</sup> T cell enrichment following CD8<sup>+</sup> T cell negative bead sorting of PBMC sample. Supplementary Material S2: Input sequences for cytokine promoters used for bisulfite reduced primer design. </p><supplementary-material id="viruses-16-01839-s001" position="float" content-type="local-data"><media xlink:href="viruses-16-01839-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Project concept and direction: M.N. with guidance from K.D.P. and J.E.F. M.N. and S.P. performed the laboratory assays and generated the primary data and M.N. analyzed the data. M.N., G.Q.D.P. and K.D.P. interpreted the data. M.N., G.Q.D.P. and K.D.P. wrote and edited the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>No ethical approval was required for this study as the study samples used were from previously completed animal studies that had appropriate approvals by the UC Davis Animal Care and Use Committee and were conducted in adherence to the guidelines of the Guide for the Care and Use of Laboratory Animals (National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC). See Methods: Animals, sample collection and processing. </p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material</xref>. Raw sequencing data can be made available on request. Further inquiries can be directed to the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-16-01839"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koup</surname><given-names>R.A.</given-names></name>
<name><surname>Safrit</surname><given-names>J.T.</given-names></name>
<name><surname>Cao</surname><given-names>Y.</given-names></name>
<name><surname>Andrews</surname><given-names>C.A.</given-names></name>
<name><surname>McLeod</surname><given-names>G.</given-names></name>
<name><surname>Borkowsky</surname><given-names>W.</given-names></name>
<name><surname>Farthing</surname><given-names>C.</given-names></name>
<name><surname>Ho</surname><given-names>D.D.</given-names></name>
</person-group><article-title>Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome</article-title><source>J. Virol.</source><year>1994</year><volume>68</volume><fpage>4650</fpage><lpage>4655</lpage><pub-id pub-id-type="doi">10.1128/jvi.68.7.4650-4655.1994</pub-id><pub-id pub-id-type="pmid">8207839</pub-id>
</element-citation></ref><ref id="B2-viruses-16-01839"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borrow</surname><given-names>P.</given-names></name>
<name><surname>Lewicki</surname><given-names>H.</given-names></name>
<name><surname>Hahn</surname><given-names>B.H.</given-names></name>
<name><surname>Shaw</surname><given-names>G.M.</given-names></name>
<name><surname>Oldstone</surname><given-names>M.B.</given-names></name>
</person-group><article-title>Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection</article-title><source>J. Virol.</source><year>1994</year><volume>68</volume><fpage>6103</fpage><lpage>6110</lpage><pub-id pub-id-type="doi">10.1128/jvi.68.9.6103-6110.1994</pub-id><pub-id pub-id-type="pmid">8057491</pub-id>
</element-citation></ref><ref id="B3-viruses-16-01839"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matano</surname><given-names>T.</given-names></name>
<name><surname>Shibata</surname><given-names>R.</given-names></name>
<name><surname>Siemon</surname><given-names>C.</given-names></name>
<name><surname>Connors</surname><given-names>M.</given-names></name>
<name><surname>Lane</surname><given-names>H.C.</given-names></name>
<name><surname>Martin</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques</article-title><source>J. Virol.</source><year>1998</year><volume>72</volume><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1128/JVI.72.1.164-169.1998</pub-id><pub-id pub-id-type="pmid">9420212</pub-id>
</element-citation></ref><ref id="B4-viruses-16-01839"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>X.</given-names></name>
<name><surname>Bauer</surname><given-names>D.E.</given-names></name>
<name><surname>Tuttleton</surname><given-names>S.E.</given-names></name>
<name><surname>Lewin</surname><given-names>S.</given-names></name>
<name><surname>Gettie</surname><given-names>A.</given-names></name>
<name><surname>Blanchard</surname><given-names>J.</given-names></name>
<name><surname>Irwin</surname><given-names>C.E.</given-names></name>
<name><surname>Safrit</surname><given-names>J.T.</given-names></name>
<name><surname>Mittler</surname><given-names>J.</given-names></name>
<name><surname>Weinberger</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques</article-title><source>J. Exp. Med.</source><year>1999</year><volume>189</volume><fpage>991</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1084/jem.189.6.991</pub-id><pub-id pub-id-type="pmid">10075982</pub-id>
</element-citation></ref><ref id="B5-viruses-16-01839"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borrow</surname><given-names>P.</given-names></name>
<name><surname>Lewicki</surname><given-names>H.</given-names></name>
<name><surname>Wei</surname><given-names>X.</given-names></name>
<name><surname>Horwitz</surname><given-names>M.S.</given-names></name>
<name><surname>Peffer</surname><given-names>N.</given-names></name>
<name><surname>Meyers</surname><given-names>H.</given-names></name>
<name><surname>Nelson</surname><given-names>J.A.</given-names></name>
<name><surname>Gairin</surname><given-names>J.E.</given-names></name>
<name><surname>Hahn</surname><given-names>B.H.</given-names></name>
<name><surname>Oldstone</surname><given-names>M.B.</given-names></name>
<etal/>
</person-group><article-title>Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus</article-title><source>Nat. Med.</source><year>1997</year><volume>3</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1038/nm0297-205</pub-id><pub-id pub-id-type="pmid">9018240</pub-id>
</element-citation></ref><ref id="B6-viruses-16-01839"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chowdhury</surname><given-names>A.</given-names></name>
<name><surname>Hayes</surname><given-names>T.L.</given-names></name>
<name><surname>Bosinger</surname><given-names>S.E.</given-names></name>
<name><surname>Lawson</surname><given-names>B.O.</given-names></name>
<name><surname>Vanderford</surname><given-names>T.</given-names></name>
<name><surname>Schmitz</surname><given-names>J.E.</given-names></name>
<name><surname>Paiardini</surname><given-names>M.</given-names></name>
<name><surname>Betts</surname><given-names>M.</given-names></name>
<name><surname>Chahroudi</surname><given-names>A.</given-names></name>
<name><surname>Estes</surname><given-names>J.D.</given-names></name>
<etal/>
</person-group><article-title>Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>8677</fpage><lpage>8686</lpage><pub-id pub-id-type="doi">10.1128/JVI.00869-15</pub-id><pub-id pub-id-type="pmid">26063417</pub-id>
</element-citation></ref><ref id="B7-viruses-16-01839"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vanderford</surname><given-names>T.H.</given-names></name>
<name><surname>Bleckwehl</surname><given-names>C.</given-names></name>
<name><surname>Engram</surname><given-names>J.C.</given-names></name>
<name><surname>Dunham</surname><given-names>R.M.</given-names></name>
<name><surname>Klatt</surname><given-names>N.R.</given-names></name>
<name><surname>Feinberg</surname><given-names>M.B.</given-names></name>
<name><surname>Garber</surname><given-names>D.A.</given-names></name>
<name><surname>Betts</surname><given-names>M.R.</given-names></name>
<name><surname>Silvestri</surname><given-names>G.</given-names></name>
</person-group><article-title>Viral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaques</article-title><source>PLoS Pathog.</source><year>2011</year><volume>7</volume><fpage>e1002048</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002048</pub-id><pub-id pub-id-type="pmid">21625590</pub-id>
</element-citation></ref><ref id="B8-viruses-16-01839"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBrien</surname><given-names>J.B.</given-names></name>
<name><surname>Kumar</surname><given-names>N.A.</given-names></name>
<name><surname>Silvestri</surname><given-names>G.</given-names></name>
</person-group><article-title>Mechanisms of CD8(+) T cell-mediated suppression of HIV/SIV replication</article-title><source>Eur. J. Immunol.</source><year>2018</year><volume>48</volume><fpage>898</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1002/eji.201747172</pub-id><pub-id pub-id-type="pmid">29427516</pub-id>
</element-citation></ref><ref id="B9-viruses-16-01839"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Connell</surname><given-names>K.A.</given-names></name>
<name><surname>Bailey</surname><given-names>J.R.</given-names></name>
<name><surname>Blankson</surname><given-names>J.N.</given-names></name>
</person-group><article-title>Elucidating the elite: Mechanisms of control in HIV-1 infection</article-title><source>Trends Pharmacol. Sci.</source><year>2009</year><volume>30</volume><fpage>631</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2009.09.005</pub-id><pub-id pub-id-type="pmid">19837464</pub-id>
</element-citation></ref><ref id="B10-viruses-16-01839"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Altfeld</surname><given-names>M.</given-names></name>
<name><surname>Addo</surname><given-names>M.M.</given-names></name>
<name><surname>Rosenberg</surname><given-names>E.S.</given-names></name>
<name><surname>Hecht</surname><given-names>F.M.</given-names></name>
<name><surname>Lee</surname><given-names>P.K.</given-names></name>
<name><surname>Vogel</surname><given-names>M.</given-names></name>
<name><surname>Yu</surname><given-names>X.G.</given-names></name>
<name><surname>Draenert</surname><given-names>R.</given-names></name>
<name><surname>Johnston</surname><given-names>M.N.</given-names></name>
<name><surname>Strick</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection</article-title><source>AIDS</source><year>2003</year><volume>17</volume><fpage>2581</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1097/00002030-200312050-00005</pub-id><pub-id pub-id-type="pmid">14685052</pub-id>
</element-citation></ref><ref id="B11-viruses-16-01839"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Evans</surname><given-names>D.T.</given-names></name>
<name><surname>Jing</surname><given-names>P.</given-names></name>
<name><surname>Allen</surname><given-names>T.M.</given-names></name>
<name><surname>O&#x02019;Connor</surname><given-names>D.H.</given-names></name>
<name><surname>Horton</surname><given-names>H.</given-names></name>
<name><surname>Venham</surname><given-names>J.E.</given-names></name>
<name><surname>Piekarczyk</surname><given-names>M.</given-names></name>
<name><surname>Dzuris</surname><given-names>J.</given-names></name>
<name><surname>Dykhuzen</surname><given-names>M.</given-names></name>
<name><surname>Mitchen</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: Evidence for an influence on disease progression</article-title><source>J. Virol.</source><year>2000</year><volume>74</volume><fpage>7400</fpage><lpage>7410</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.16.7400-7410.2000</pub-id><pub-id pub-id-type="pmid">10906193</pub-id>
</element-citation></ref><ref id="B12-viruses-16-01839"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valentine</surname><given-names>L.E.</given-names></name>
<name><surname>Watkins</surname><given-names>D.I.</given-names></name>
</person-group><article-title>Relevance of studying T cell responses in SIV-infected rhesus macaques</article-title><source>Trends Microbiol.</source><year>2008</year><volume>16</volume><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2008.08.010</pub-id><pub-id pub-id-type="pmid">18964016</pub-id>
</element-citation></ref><ref id="B13-viruses-16-01839"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>S.</given-names></name>
<name><surname>Sada-Japp</surname><given-names>A.</given-names></name>
<name><surname>Petrovas</surname><given-names>C.</given-names></name>
<name><surname>Betts</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Jigsaw falling into place: A review and perspective of lymphoid tissue CD8+ T cells and control of HIV</article-title><source>Mol. Immunol.</source><year>2020</year><volume>124</volume><fpage>42</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2020.05.016</pub-id><pub-id pub-id-type="pmid">32526556</pub-id>
</element-citation></ref><ref id="B14-viruses-16-01839"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andersson</surname><given-names>J.</given-names></name>
<name><surname>Kinloch</surname><given-names>S.</given-names></name>
<name><surname>Sonnerborg</surname><given-names>A.</given-names></name>
<name><surname>Nilsson</surname><given-names>J.</given-names></name>
<name><surname>Fehniger</surname><given-names>T.E.</given-names></name>
<name><surname>Spetz</surname><given-names>A.L.</given-names></name>
<name><surname>Behbahani</surname><given-names>H.</given-names></name>
<name><surname>Goh</surname><given-names>L.E.</given-names></name>
<name><surname>McDade</surname><given-names>H.</given-names></name>
<name><surname>Gazzard</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection</article-title><source>J. Infect. Dis.</source><year>2002</year><volume>185</volume><fpage>1355</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.1086/340124</pub-id><pub-id pub-id-type="pmid">12001057</pub-id>
</element-citation></ref><ref id="B15-viruses-16-01839"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reuter</surname><given-names>M.A.</given-names></name>
<name><surname>Del Rio Estrada</surname><given-names>P.M.</given-names></name>
<name><surname>Buggert</surname><given-names>M.</given-names></name>
<name><surname>Petrovas</surname><given-names>C.</given-names></name>
<name><surname>Ferrando-Martinez</surname><given-names>S.</given-names></name>
<name><surname>Nguyen</surname><given-names>S.</given-names></name>
<name><surname>Sada Japp</surname><given-names>A.</given-names></name>
<name><surname>Ablanedo-Terrazas</surname><given-names>Y.</given-names></name>
<name><surname>Rivero-Arrieta</surname><given-names>A.</given-names></name>
<name><surname>Kuri-Cervantes</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>HIV-Specific CD8(+) T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue</article-title><source>Cell Rep.</source><year>2017</year><volume>21</volume><fpage>3458</fpage><lpage>3470</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.11.075</pub-id><pub-id pub-id-type="pmid">29262326</pub-id>
</element-citation></ref><ref id="B16-viruses-16-01839"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kiniry</surname><given-names>B.E.</given-names></name>
<name><surname>Ganesh</surname><given-names>A.</given-names></name>
<name><surname>Critchfield</surname><given-names>J.W.</given-names></name>
<name><surname>Hunt</surname><given-names>P.W.</given-names></name>
<name><surname>Hecht</surname><given-names>F.M.</given-names></name>
<name><surname>Somsouk</surname><given-names>M.</given-names></name>
<name><surname>Deeks</surname><given-names>S.G.</given-names></name>
<name><surname>Shacklett</surname><given-names>B.L.</given-names></name>
</person-group><article-title>Predominance of weakly cytotoxic, T-bet(Low)Eomes(Neg) CD8(+) T-cells in human gastrointestinal mucosa: Implications for HIV infection</article-title><source>Mucosal Immunol.</source><year>2017</year><volume>10</volume><fpage>1008</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1038/mi.2016.100</pub-id><pub-id pub-id-type="pmid">27827375</pub-id>
</element-citation></ref><ref id="B17-viruses-16-01839"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kiniry</surname><given-names>B.E.</given-names></name>
<name><surname>Hunt</surname><given-names>P.W.</given-names></name>
<name><surname>Hecht</surname><given-names>F.M.</given-names></name>
<name><surname>Somsouk</surname><given-names>M.</given-names></name>
<name><surname>Deeks</surname><given-names>S.G.</given-names></name>
<name><surname>Shacklett</surname><given-names>B.L.</given-names></name>
</person-group><article-title>Differential Expression of CD8(+) T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection</article-title><source>J. Immunol.</source><year>2018</year><volume>200</volume><fpage>1876</fpage><lpage>1888</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1701532</pub-id><pub-id pub-id-type="pmid">29352005</pub-id>
</element-citation></ref><ref id="B18-viruses-16-01839"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kiniry</surname><given-names>B.E.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Ganesh</surname><given-names>A.</given-names></name>
<name><surname>Hunt</surname><given-names>P.W.</given-names></name>
<name><surname>Somsouk</surname><given-names>M.</given-names></name>
<name><surname>Skinner</surname><given-names>P.J.</given-names></name>
<name><surname>Deeks</surname><given-names>S.G.</given-names></name>
<name><surname>Shacklett</surname><given-names>B.L.</given-names></name>
</person-group><article-title>Detection of HIV-1-specific gastrointestinal tissue resident CD8(+) T-cells in chronic infection</article-title><source>Mucosal Immunol.</source><year>2018</year><volume>11</volume><fpage>909</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1038/mi.2017.96</pub-id><pub-id pub-id-type="pmid">29139476</pub-id>
</element-citation></ref><ref id="B19-viruses-16-01839"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>W.</given-names></name>
<name><surname>Mehraj</surname><given-names>V.</given-names></name>
<name><surname>Kaufmann</surname><given-names>D.E.</given-names></name>
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Routy</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Elevation and persistence of CD8 T-cells in HIV infection: The Achilles heel in the ART era</article-title><source>J. Int. AIDS Soc.</source><year>2016</year><volume>19</volume><fpage>20697</fpage><pub-id pub-id-type="doi">10.7448/IAS.19.1.20697</pub-id><pub-id pub-id-type="pmid">26945343</pub-id>
</element-citation></ref><ref id="B20-viruses-16-01839"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuchroo</surname><given-names>V.K.</given-names></name>
<name><surname>Anderson</surname><given-names>A.C.</given-names></name>
<name><surname>Petrovas</surname><given-names>C.</given-names></name>
</person-group><article-title>Coinhibitory receptors and CD8 T cell exhaustion in chronic infections</article-title><source>Curr. Opin. HIV AIDS</source><year>2014</year><volume>9</volume><fpage>439</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000088</pub-id><pub-id pub-id-type="pmid">25010894</pub-id>
</element-citation></ref><ref id="B21-viruses-16-01839"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fenwick</surname><given-names>C.</given-names></name>
<name><surname>Joo</surname><given-names>V.</given-names></name>
<name><surname>Jacquier</surname><given-names>P.</given-names></name>
<name><surname>Noto</surname><given-names>A.</given-names></name>
<name><surname>Banga</surname><given-names>R.</given-names></name>
<name><surname>Perreau</surname><given-names>M.</given-names></name>
<name><surname>Pantaleo</surname><given-names>G.</given-names></name>
</person-group><article-title>T-cell exhaustion in HIV infection</article-title><source>Immunol. Rev.</source><year>2019</year><volume>292</volume><fpage>149</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1111/imr.12823</pub-id><pub-id pub-id-type="pmid">31883174</pub-id>
</element-citation></ref><ref id="B22-viruses-16-01839"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Georgountzou</surname><given-names>A.</given-names></name>
<name><surname>Papadopoulos</surname><given-names>N.G.</given-names></name>
</person-group><article-title>Postnatal Innate Immune Development: From Birth to Adulthood</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>957</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00957</pub-id><pub-id pub-id-type="pmid">28848557</pub-id>
</element-citation></ref><ref id="B23-viruses-16-01839"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adkins</surname><given-names>B.</given-names></name>
<name><surname>Leclerc</surname><given-names>C.</given-names></name>
<name><surname>Marshall-Clarke</surname><given-names>S.</given-names></name>
</person-group><article-title>Neonatal adaptive immunity comes of age</article-title><source>Nat. Rev. Immunol.</source><year>2004</year><volume>4</volume><fpage>553</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1038/nri1394</pub-id><pub-id pub-id-type="pmid">15229474</pub-id>
</element-citation></ref><ref id="B24-viruses-16-01839"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Levy</surname><given-names>O.</given-names></name>
</person-group><article-title>Innate immunity of the human newborn: Distinct cytokine responses to LPS and other Toll-like receptor agonists</article-title><source>J. Endotoxin Res.</source><year>2005</year><volume>11</volume><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1177/09680519050110020701</pub-id><pub-id pub-id-type="pmid">15949138</pub-id>
</element-citation></ref><ref id="B25-viruses-16-01839"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dowling</surname><given-names>D.J.</given-names></name>
<name><surname>Levy</surname><given-names>O.</given-names></name>
</person-group><article-title>Ontogeny of early life immunity</article-title><source>Trends Immunol.</source><year>2014</year><volume>35</volume><fpage>299</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.it.2014.04.007</pub-id><pub-id pub-id-type="pmid">24880460</pub-id>
</element-citation></ref><ref id="B26-viruses-16-01839"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Slyker</surname><given-names>J.A.</given-names></name>
<name><surname>John-Stewart</surname><given-names>G.C.</given-names></name>
<name><surname>Dong</surname><given-names>T.</given-names></name>
<name><surname>Lohman-Payne</surname><given-names>B.</given-names></name>
<name><surname>Reilly</surname><given-names>M.</given-names></name>
<name><surname>Atzberger</surname><given-names>A.</given-names></name>
<name><surname>Taylor</surname><given-names>S.</given-names></name>
<name><surname>Maleche-Obimbo</surname><given-names>E.</given-names></name>
<name><surname>Mbori-Ngacha</surname><given-names>D.</given-names></name>
<name><surname>Rowland-Jones</surname><given-names>S.L.</given-names></name>
</person-group><article-title>Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e20375</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0020375</pub-id><pub-id pub-id-type="pmid">21655252</pub-id>
</element-citation></ref><ref id="B27-viruses-16-01839"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roider</surname><given-names>J.M.</given-names></name>
<name><surname>Muenchhoff</surname><given-names>M.</given-names></name>
<name><surname>Goulder</surname><given-names>P.J.</given-names></name>
</person-group><article-title>Immune activation and paediatric HIV-1 disease outcome</article-title><source>Curr. Opin. HIV AIDS</source><year>2016</year><volume>11</volume><fpage>146</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000231</pub-id><pub-id pub-id-type="pmid">26679413</pub-id>
</element-citation></ref><ref id="B28-viruses-16-01839"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leitman</surname><given-names>E.M.</given-names></name>
<name><surname>Thobakgale</surname><given-names>C.F.</given-names></name>
<name><surname>Adland</surname><given-names>E.</given-names></name>
<name><surname>Ansari</surname><given-names>M.A.</given-names></name>
<name><surname>Raghwani</surname><given-names>J.</given-names></name>
<name><surname>Prendergast</surname><given-names>A.J.</given-names></name>
<name><surname>Tudor-Williams</surname><given-names>G.</given-names></name>
<name><surname>Kiepiela</surname><given-names>P.</given-names></name>
<name><surname>Hemelaar</surname><given-names>J.</given-names></name>
<name><surname>Brener</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Role of HIV-specific CD8(+) T cells in pediatric HIV cure strategies after widespread early viral escape</article-title><source>J. Exp. Med.</source><year>2017</year><volume>214</volume><fpage>3239</fpage><lpage>3261</lpage><pub-id pub-id-type="doi">10.1084/jem.20162123</pub-id><pub-id pub-id-type="pmid">28983013</pub-id>
</element-citation></ref><ref id="B29-viruses-16-01839"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adland</surname><given-names>E.</given-names></name>
<name><surname>Paioni</surname><given-names>P.</given-names></name>
<name><surname>Thobakgale</surname><given-names>C.</given-names></name>
<name><surname>Laker</surname><given-names>L.</given-names></name>
<name><surname>Mori</surname><given-names>L.</given-names></name>
<name><surname>Muenchhoff</surname><given-names>M.</given-names></name>
<name><surname>Csala</surname><given-names>A.</given-names></name>
<name><surname>Clapson</surname><given-names>M.</given-names></name>
<name><surname>Flynn</surname><given-names>J.</given-names></name>
<name><surname>Novelli</surname><given-names>V.</given-names></name>
<etal/>
</person-group><article-title>Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection</article-title><source>PLoS Pathog.</source><year>2015</year><volume>11</volume><fpage>e1004954</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004954</pub-id><pub-id pub-id-type="pmid">26076345</pub-id>
</element-citation></ref><ref id="B30-viruses-16-01839"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chappell</surname><given-names>C.</given-names></name>
<name><surname>Beard</surname><given-names>C.</given-names></name>
<name><surname>Altman</surname><given-names>J.</given-names></name>
<name><surname>Jaenisch</surname><given-names>R.</given-names></name>
<name><surname>Jacob</surname><given-names>J.</given-names></name>
</person-group><article-title>DNA methylation by DNA methyltransferase 1 is critical for effector CD8 T cell expansion</article-title><source>J. Immunol.</source><year>2006</year><volume>176</volume><fpage>4562</fpage><lpage>4572</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.8.4562</pub-id><pub-id pub-id-type="pmid">16585546</pub-id>
</element-citation></ref><ref id="B31-viruses-16-01839"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nag</surname><given-names>M.</given-names></name>
<name><surname>De Paris</surname><given-names>K.</given-names></name>
<name><surname>Fogle</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Epigenetic Modulation of CD8(+) T Cell Function in Lentivirus Infections: A Review</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>227</elocation-id><pub-id pub-id-type="doi">10.3390/v10050227</pub-id><pub-id pub-id-type="pmid">29710792</pub-id>
</element-citation></ref><ref id="B32-viruses-16-01839"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Correa</surname><given-names>L.O.</given-names></name>
<name><surname>Jordan</surname><given-names>M.S.</given-names></name>
<name><surname>Carty</surname><given-names>S.A.</given-names></name>
</person-group><article-title>DNA Methylation in T-Cell Development and Differentiation</article-title><source>Crit. Rev. Immunol.</source><year>2020</year><volume>40</volume><fpage>135</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1615/CritRevImmunol.2020033728</pub-id><pub-id pub-id-type="pmid">32749092</pub-id>
</element-citation></ref><ref id="B33-viruses-16-01839"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scharer</surname><given-names>C.D.</given-names></name>
<name><surname>Barwick</surname><given-names>B.G.</given-names></name>
<name><surname>Youngblood</surname><given-names>B.A.</given-names></name>
<name><surname>Ahmed</surname><given-names>R.</given-names></name>
<name><surname>Boss</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Global DNA methylation remodeling accompanies CD8 T cell effector function</article-title><source>J. Immunol.</source><year>2013</year><volume>191</volume><fpage>3419</fpage><lpage>3429</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301395</pub-id><pub-id pub-id-type="pmid">23956425</pub-id>
</element-citation></ref><ref id="B34-viruses-16-01839"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belk</surname><given-names>J.A.</given-names></name>
<name><surname>Daniel</surname><given-names>B.</given-names></name>
<name><surname>Satpathy</surname><given-names>A.T.</given-names></name>
</person-group><article-title>Epigenetic regulation of T cell exhaustion</article-title><source>Nat. Immunol.</source><year>2022</year><volume>23</volume><fpage>848</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1038/s41590-022-01224-z</pub-id><pub-id pub-id-type="pmid">35624210</pub-id>
</element-citation></ref><ref id="B35-viruses-16-01839"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Youngblood</surname><given-names>B.</given-names></name>
<name><surname>Noto</surname><given-names>A.</given-names></name>
<name><surname>Porichis</surname><given-names>F.</given-names></name>
<name><surname>Akondy</surname><given-names>R.S.</given-names></name>
<name><surname>Ndhlovu</surname><given-names>Z.M.</given-names></name>
<name><surname>Austin</surname><given-names>J.W.</given-names></name>
<name><surname>Bordi</surname><given-names>R.</given-names></name>
<name><surname>Procopio</surname><given-names>F.A.</given-names></name>
<name><surname>Miura</surname><given-names>T.</given-names></name>
<name><surname>Allen</surname><given-names>T.M.</given-names></name>
<etal/>
</person-group><article-title>Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells</article-title><source>J. Immunol.</source><year>2013</year><volume>191</volume><fpage>540</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203161</pub-id><pub-id pub-id-type="pmid">23772031</pub-id>
</element-citation></ref><ref id="B36-viruses-16-01839"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>L.D.</given-names></name>
<name><surname>Le</surname><given-names>T.</given-names></name>
<name><surname>Fan</surname><given-names>G.</given-names></name>
</person-group><article-title>DNA methylation and its basic function</article-title><source>Neuropsychopharmacology</source><year>2013</year><volume>38</volume><fpage>23</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1038/npp.2012.112</pub-id><pub-id pub-id-type="pmid">22781841</pub-id>
</element-citation></ref><ref id="B37-viruses-16-01839"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Curtis</surname><given-names>A.D.</given-names><suffix>2nd</suffix></name>
<name><surname>Dennis</surname><given-names>M.</given-names></name>
<name><surname>Eudailey</surname><given-names>J.</given-names></name>
<name><surname>Walter</surname><given-names>K.L.</given-names></name>
<name><surname>Cronin</surname><given-names>K.</given-names></name>
<name><surname>Alam</surname><given-names>S.M.</given-names></name>
<name><surname>Choudhary</surname><given-names>N.</given-names></name>
<name><surname>Tuck</surname><given-names>R.H.</given-names></name>
<name><surname>Hudgens</surname><given-names>M.</given-names></name>
<name><surname>Kozlowski</surname><given-names>P.A.</given-names></name>
<etal/>
</person-group><article-title>HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy</article-title><source>mSphere</source><year>2020</year><volume>5</volume><fpage>10</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1128/mSphere.00162-20</pub-id></element-citation></ref><ref id="B38-viruses-16-01839"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>K.</given-names></name>
<name><surname>Nabi</surname><given-names>R.</given-names></name>
<name><surname>Van Rompay</surname><given-names>K.K.A.</given-names></name>
<name><surname>Robichaux</surname><given-names>S.</given-names></name>
<name><surname>Lifson</surname><given-names>J.D.</given-names></name>
<name><surname>Piatak</surname><given-names>M.</given-names><suffix>Jr.</suffix></name>
<name><surname>Jacobs</surname><given-names>W.R.</given-names><suffix>Jr.</suffix></name>
<name><surname>Fennelly</surname><given-names>G.</given-names></name>
<name><surname>Canfield</surname><given-names>D.</given-names></name>
<name><surname>Mollan</surname><given-names>K.R.</given-names></name>
<etal/>
</person-group><article-title>Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques</article-title><source>J. Virol.</source><year>2016</year><volume>90</volume><fpage>7285</fpage><lpage>7302</lpage><pub-id pub-id-type="doi">10.1128/JVI.00481-16</pub-id><pub-id pub-id-type="pmid">27252535</pub-id>
</element-citation></ref><ref id="B39-viruses-16-01839"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>K.</given-names></name>
<name><surname>Dela Pena-Ponce</surname><given-names>M.G.</given-names></name>
<name><surname>Piatak</surname><given-names>M.</given-names><suffix>Jr.</suffix></name>
<name><surname>Shoemaker</surname><given-names>R.</given-names></name>
<name><surname>Oswald</surname><given-names>K.</given-names></name>
<name><surname>Jacobs</surname><given-names>W.R.</given-names><suffix>Jr.</suffix></name>
<name><surname>Fennelly</surname><given-names>G.</given-names></name>
<name><surname>Lucero</surname><given-names>C.</given-names></name>
<name><surname>Mollan</surname><given-names>K.R.</given-names></name>
<name><surname>Hudgens</surname><given-names>M.G.</given-names></name>
<etal/>
</person-group><article-title>Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine</article-title><source>Clin. Vaccine Immunol.</source><year>2017</year><volume>24</volume><fpage>e00360-16</fpage><pub-id pub-id-type="doi">10.1128/CVI.00360-16</pub-id><pub-id pub-id-type="pmid">27655885</pub-id>
</element-citation></ref><ref id="B40-viruses-16-01839"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dwyer</surname><given-names>J.M.</given-names></name>
<name><surname>Johnson</surname><given-names>C.</given-names></name>
</person-group><article-title>The use of concanavalin A to study the immunoregulation of human T cells</article-title><source>Clin. Exp. Immunol.</source><year>1981</year><volume>46</volume><fpage>237</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">6461456</pub-id>
</element-citation></ref><ref id="B41-viruses-16-01839"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Messeguer</surname><given-names>X.</given-names></name>
<name><surname>Escudero</surname><given-names>R.</given-names></name>
<name><surname>Farre</surname><given-names>D.</given-names></name>
<name><surname>Nunez</surname><given-names>O.</given-names></name>
<name><surname>Martinez</surname><given-names>J.</given-names></name>
<name><surname>Alba</surname><given-names>M.M.</given-names></name>
</person-group><article-title>PROMO: Detection of known transcription regulatory elements using species-tailored searches</article-title><source>Bioinformatics</source><year>2002</year><volume>18</volume><fpage>333</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/18.2.333</pub-id><pub-id pub-id-type="pmid">11847087</pub-id>
</element-citation></ref><ref id="B42-viruses-16-01839"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farre</surname><given-names>D.</given-names></name>
<name><surname>Roset</surname><given-names>R.</given-names></name>
<name><surname>Huerta</surname><given-names>M.</given-names></name>
<name><surname>Adsuara</surname><given-names>J.E.</given-names></name>
<name><surname>Rosello</surname><given-names>L.</given-names></name>
<name><surname>Alba</surname><given-names>M.M.</given-names></name>
<name><surname>Messeguer</surname><given-names>X.</given-names></name>
</person-group><article-title>Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN</article-title><source>Nucleic Acids Res.</source><year>2003</year><volume>31</volume><fpage>3651</fpage><lpage>3653</lpage><pub-id pub-id-type="doi">10.1093/nar/gkg605</pub-id><pub-id pub-id-type="pmid">12824386</pub-id>
</element-citation></ref><ref id="B43-viruses-16-01839"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Tollefsbol</surname><given-names>T.O.</given-names></name>
</person-group><article-title>DNA methylation methods: Global DNA methylation and methylomic analyses</article-title><source>Methods</source><year>2021</year><volume>187</volume><fpage>28</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2020.10.002</pub-id><pub-id pub-id-type="pmid">33039572</pub-id>
</element-citation></ref><ref id="B44-viruses-16-01839"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Betts</surname><given-names>M.R.</given-names></name>
<name><surname>Nason</surname><given-names>M.C.</given-names></name>
<name><surname>West</surname><given-names>S.M.</given-names></name>
<name><surname>De Rosa</surname><given-names>S.C.</given-names></name>
<name><surname>Migueles</surname><given-names>S.A.</given-names></name>
<name><surname>Abraham</surname><given-names>J.</given-names></name>
<name><surname>Lederman</surname><given-names>M.M.</given-names></name>
<name><surname>Benito</surname><given-names>J.M.</given-names></name>
<name><surname>Goepfert</surname><given-names>P.A.</given-names></name>
<name><surname>Connors</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells</article-title><source>Blood</source><year>2006</year><volume>107</volume><fpage>4781</fpage><lpage>4789</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-12-4818</pub-id><pub-id pub-id-type="pmid">16467198</pub-id>
</element-citation></ref><ref id="B45-viruses-16-01839"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Freel</surname><given-names>S.A.</given-names></name>
<name><surname>Saunders</surname><given-names>K.O.</given-names></name>
<name><surname>Tomaras</surname><given-names>G.D.</given-names></name>
</person-group><article-title>CD8(+)T-cell-mediated control of HIV-1 and SIV infection</article-title><source>Immunol. Res.</source><year>2011</year><volume>49</volume><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1007/s12026-010-8177-7</pub-id><pub-id pub-id-type="pmid">21170741</pub-id>
</element-citation></ref><ref id="B46-viruses-16-01839"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Mendoza</surname><given-names>A.</given-names></name>
<name><surname>Nguyen</surname><given-names>T.V.</given-names></name>
<name><surname>Ford</surname><given-names>E.</given-names></name>
<name><surname>Poppe</surname><given-names>D.</given-names></name>
<name><surname>Buckberry</surname><given-names>S.</given-names></name>
<name><surname>Pflueger</surname><given-names>J.</given-names></name>
<name><surname>Grimmer</surname><given-names>M.R.</given-names></name>
<name><surname>Stolzenburg</surname><given-names>S.</given-names></name>
<name><surname>Bogdanovic</surname><given-names>O.</given-names></name>
<name><surname>Oshlack</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stability</article-title><source>Genome Biol.</source><year>2022</year><volume>23</volume><fpage>163</fpage><pub-id pub-id-type="doi">10.1186/s13059-022-02728-5</pub-id><pub-id pub-id-type="pmid">35883107</pub-id>
</element-citation></ref><ref id="B47-viruses-16-01839"><label>47.</label><element-citation publication-type="webpage"><article-title>Treatment Action Group</article-title><comment>Available online: <ext-link xlink:href="https://www.treatmentactiongroup.org/" ext-link-type="uri">https://www.treatmentactiongroup.org/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-01-09">(accessed on 9 January 2024)</date-in-citation></element-citation></ref><ref id="B48-viruses-16-01839"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gulzar</surname><given-names>N.</given-names></name>
<name><surname>Copeland</surname><given-names>K.F.</given-names></name>
</person-group><article-title>CD8+ T-cells: Function and response to HIV infection</article-title><source>Curr. HIV Res.</source><year>2004</year><volume>2</volume><fpage>23</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.2174/1570162043485077</pub-id><pub-id pub-id-type="pmid">15053338</pub-id>
</element-citation></ref><ref id="B49-viruses-16-01839"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Breen</surname><given-names>E.C.</given-names></name>
<name><surname>Salazar-Gonzalez</surname><given-names>J.F.</given-names></name>
<name><surname>Shen</surname><given-names>L.P.</given-names></name>
<name><surname>Kolberg</surname><given-names>J.A.</given-names></name>
<name><surname>Urdea</surname><given-names>M.S.</given-names></name>
<name><surname>Martinez-Maza</surname><given-names>O.</given-names></name>
<name><surname>Fahey</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Circulating CD8 T cells show increased interferon-gamma mRNA expression in HIV infection</article-title><source>Cell Immunol.</source><year>1997</year><volume>178</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1006/cimm.1997.1115</pub-id><pub-id pub-id-type="pmid">9184702</pub-id>
</element-citation></ref><ref id="B50-viruses-16-01839"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stacey</surname><given-names>A.R.</given-names></name>
<name><surname>Norris</surname><given-names>P.J.</given-names></name>
<name><surname>Qin</surname><given-names>L.</given-names></name>
<name><surname>Haygreen</surname><given-names>E.A.</given-names></name>
<name><surname>Taylor</surname><given-names>E.</given-names></name>
<name><surname>Heitman</surname><given-names>J.</given-names></name>
<name><surname>Lebedeva</surname><given-names>M.</given-names></name>
<name><surname>DeCamp</surname><given-names>A.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Grove</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections</article-title><source>J. Virol.</source><year>2009</year><volume>83</volume><fpage>3719</fpage><lpage>3733</lpage><pub-id pub-id-type="doi">10.1128/JVI.01844-08</pub-id><pub-id pub-id-type="pmid">19176632</pub-id>
</element-citation></ref><ref id="B51-viruses-16-01839"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zanussi</surname><given-names>S.</given-names></name>
<name><surname>Simonelli</surname><given-names>C.</given-names></name>
<name><surname>D&#x02019;Andrea</surname><given-names>M.</given-names></name>
<name><surname>Caffau</surname><given-names>C.</given-names></name>
<name><surname>Clerici</surname><given-names>M.</given-names></name>
<name><surname>Tirelli</surname><given-names>U.</given-names></name>
<name><surname>DePaoli</surname><given-names>P.</given-names></name>
</person-group><article-title>CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection</article-title><source>Clin. Exp. Immunol.</source><year>1996</year><volume>105</volume><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.1996.d01-746.x</pub-id><pub-id pub-id-type="pmid">8706325</pub-id>
</element-citation></ref><ref id="B52-viruses-16-01839"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crabtree</surname><given-names>G.R.</given-names></name>
<name><surname>Clipstone</surname><given-names>N.A.</given-names></name>
</person-group><article-title>Signal transmission between the plasma membrane and nucleus of T lymphocytes</article-title><source>Annu. Rev. Biochem.</source><year>1994</year><volume>63</volume><fpage>1045</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.63.070194.005145</pub-id><pub-id pub-id-type="pmid">7979236</pub-id>
</element-citation></ref><ref id="B53-viruses-16-01839"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bruniquel</surname><given-names>D.</given-names></name>
<name><surname>Schwartz</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process</article-title><source>Nat. Immunol.</source><year>2003</year><volume>4</volume><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1038/ni887</pub-id><pub-id pub-id-type="pmid">12548284</pub-id>
</element-citation></ref><ref id="B54-viruses-16-01839"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murayama</surname><given-names>A.</given-names></name>
<name><surname>Sakura</surname><given-names>K.</given-names></name>
<name><surname>Nakama</surname><given-names>M.</given-names></name>
<name><surname>Yasuzawa-Tanaka</surname><given-names>K.</given-names></name>
<name><surname>Fujita</surname><given-names>E.</given-names></name>
<name><surname>Tateishi</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Ushijima</surname><given-names>T.</given-names></name>
<name><surname>Baba</surname><given-names>T.</given-names></name>
<name><surname>Shibuya</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory</article-title><source>EMBO J.</source><year>2006</year><volume>25</volume><fpage>1081</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601012</pub-id><pub-id pub-id-type="pmid">16498406</pub-id>
</element-citation></ref><ref id="B55-viruses-16-01839"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakayama-Hosoya</surname><given-names>K.</given-names></name>
<name><surname>Ishida</surname><given-names>T.</given-names></name>
<name><surname>Youngblood</surname><given-names>B.</given-names></name>
<name><surname>Nakamura</surname><given-names>H.</given-names></name>
<name><surname>Hosoya</surname><given-names>N.</given-names></name>
<name><surname>Koga</surname><given-names>M.</given-names></name>
<name><surname>Koibuchi</surname><given-names>T.</given-names></name>
<name><surname>Iwamoto</surname><given-names>A.</given-names></name>
<name><surname>Kawana-Tachikawa</surname><given-names>A.</given-names></name>
</person-group><article-title>Epigenetic repression of interleukin 2 expression in senescent CD4+ T cells during chronic HIV type 1 infection</article-title><source>J. Infect. Dis.</source><year>2015</year><volume>211</volume><fpage>28</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiu376</pub-id><pub-id pub-id-type="pmid">25001463</pub-id>
</element-citation></ref><ref id="B56-viruses-16-01839"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>A.</given-names></name>
<name><surname>Abbas</surname><given-names>W.</given-names></name>
<name><surname>Herbein</surname><given-names>G.</given-names></name>
</person-group><article-title>TNF and TNF receptor superfamily members in HIV infection: New cellular targets for therapy?</article-title><source>Mediators Inflamm.</source><year>2013</year><volume>2013</volume><fpage>484378</fpage><pub-id pub-id-type="doi">10.1155/2013/484378</pub-id><pub-id pub-id-type="pmid">24453421</pub-id>
</element-citation></ref><ref id="B57-viruses-16-01839"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brenchley</surname><given-names>J.M.</given-names></name>
<name><surname>Douek</surname><given-names>D.C.</given-names></name>
</person-group><article-title>HIV infection and the gastrointestinal immune system</article-title><source>Mucosal Immunol.</source><year>2008</year><volume>1</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/mi.2007.1</pub-id><pub-id pub-id-type="pmid">19079157</pub-id>
</element-citation></ref><ref id="B58-viruses-16-01839"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buggert</surname><given-names>M.</given-names></name>
<name><surname>Japp</surname><given-names>A.S.</given-names></name>
<name><surname>Betts</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Everything in its right place: Resident memory CD8+ T cell immunosurveillance of HIV infection</article-title><source>Curr. Opin. HIV AIDS</source><year>2019</year><volume>14</volume><fpage>93</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000523</pub-id><pub-id pub-id-type="pmid">30520744</pub-id>
</element-citation></ref><ref id="B59-viruses-16-01839"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gonzalez</surname><given-names>S.M.</given-names></name>
<name><surname>Taborda</surname><given-names>N.A.</given-names></name>
<name><surname>Rugeles</surname><given-names>M.T.</given-names></name>
</person-group><article-title>Role of Different Subpopulations of CD8(+) T Cells during HIV Exposure and Infection</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>936</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00936</pub-id><pub-id pub-id-type="pmid">28824656</pub-id>
</element-citation></ref><ref id="B60-viruses-16-01839"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beck</surname><given-names>S.E.</given-names></name>
<name><surname>Veenhuis</surname><given-names>R.T.</given-names></name>
<name><surname>Blankson</surname><given-names>J.N.</given-names></name>
</person-group><article-title>Does B Cell Follicle Exclusion of CD8+ T Cells Make Lymph Nodes Sanctuaries of HIV Replication?</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>2362</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.02362</pub-id><pub-id pub-id-type="pmid">31649673</pub-id>
</element-citation></ref><ref id="B61-viruses-16-01839"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Connick</surname><given-names>E.</given-names></name>
<name><surname>Mattila</surname><given-names>T.</given-names></name>
<name><surname>Folkvord</surname><given-names>J.M.</given-names></name>
<name><surname>Schlichtemeier</surname><given-names>R.</given-names></name>
<name><surname>Meditz</surname><given-names>A.L.</given-names></name>
<name><surname>Ray</surname><given-names>M.G.</given-names></name>
<name><surname>McCarter</surname><given-names>M.D.</given-names></name>
<name><surname>Mawhinney</surname><given-names>S.</given-names></name>
<name><surname>Hage</surname><given-names>A.</given-names></name>
<name><surname>White</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>6975</fpage><lpage>6983</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.11.6975</pub-id><pub-id pub-id-type="pmid">17513747</pub-id>
</element-citation></ref><ref id="B62-viruses-16-01839"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schreurs</surname><given-names>R.</given-names></name>
<name><surname>Sagebiel</surname><given-names>A.F.</given-names></name>
<name><surname>Steinert</surname><given-names>F.L.</given-names></name>
<name><surname>Highton</surname><given-names>A.J.</given-names></name>
<name><surname>Klarenbeek</surname><given-names>P.L.</given-names></name>
<name><surname>Drewniak</surname><given-names>A.</given-names></name>
<name><surname>Bakx</surname><given-names>R.</given-names></name>
<name><surname>The</surname><given-names>S.M.L.</given-names></name>
<name><surname>Ribeiro</surname><given-names>C.M.S.</given-names></name>
<name><surname>Perez</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Intestinal CD8(+) T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities</article-title><source>Mucosal Immunol.</source><year>2021</year><volume>14</volume><fpage>605</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1038/s41385-021-00382-x</pub-id><pub-id pub-id-type="pmid">33772147</pub-id>
</element-citation></ref><ref id="B63-viruses-16-01839"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buggert</surname><given-names>M.</given-names></name>
<name><surname>Nguyen</surname><given-names>S.</given-names></name>
<name><surname>Salgado-Montes de Oca</surname><given-names>G.</given-names></name>
<name><surname>Bengsch</surname><given-names>B.</given-names></name>
<name><surname>Darko</surname><given-names>S.</given-names></name>
<name><surname>Ransier</surname><given-names>A.</given-names></name>
<name><surname>Roberts</surname><given-names>E.R.</given-names></name>
<name><surname>Del Alcazar</surname><given-names>D.</given-names></name>
<name><surname>Brody</surname><given-names>I.B.</given-names></name>
<name><surname>Vella</surname><given-names>L.A.</given-names></name>
<etal/>
</person-group><article-title>Identification and characterization of HIV-specific resident memory CD8(+) T cells in human lymphoid tissue</article-title><source>Sci. Immunol.</source><year>2018</year><volume>3</volume><fpage>eaar4526</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aar4526</pub-id><pub-id pub-id-type="pmid">29858286</pub-id>
</element-citation></ref><ref id="B64-viruses-16-01839"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strongin</surname><given-names>Z.</given-names></name>
<name><surname>Raymond Marchand</surname><given-names>L.</given-names></name>
<name><surname>Deleage</surname><given-names>C.</given-names></name>
<name><surname>Pampena</surname><given-names>M.B.</given-names></name>
<name><surname>Cardenas</surname><given-names>M.A.</given-names></name>
<name><surname>Beusch</surname><given-names>C.M.</given-names></name>
<name><surname>Hoang</surname><given-names>T.N.</given-names></name>
<name><surname>Urban</surname><given-names>E.A.</given-names></name>
<name><surname>Gourves</surname><given-names>M.</given-names></name>
<name><surname>Nguyen</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Distinct SIV-specific CD8(+) T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence</article-title><source>Nat. Immunol.</source><year>2024</year><volume>25</volume><fpage>1245</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1038/s41590-024-01875-0</pub-id><pub-id pub-id-type="pmid">38886592</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-16-01839-f001"><label>Figure 1</label><caption><p>Global DNA methylation levels of CD8<sup>+</sup> T cells derived from PBMCs, lymph nodes, and intestinal tissues of SIV uninfected and infected rhesus macaques. Methylation levels were quantitated for genomic DNA isolated from bulk CD8<sup>+</sup> T cells derived from paired PBMCs pre- and post-SIV infection (<bold>A</bold>), and from lymph nodes and intestinal tissues of unpaired SIV-uninfected and SIV-infected rhesus macaques (<bold>B</bold>). Panel (<bold>A</bold>): Change in DNA methylation post (orange symbols)- versus pre (blue symbols)- infection within the same animal (n = 4). Data represent the average methylation levels from 3 technical replicates per animal, with each animal being represented by a unique symbol. Statistical significance was determined by a two-tailed paired <italic toggle="yes">t</italic>-test in GraphPad Prism. Panel (<bold>B</bold>): Mean DNA methylation levels &#x000b1; standard deviation in lymph nodes (light-colored symbols) and intestinal (dark-colored symbols) tissues of 4 SIV uninfected (green and olive symbols) and 3 SIV infected (pink and purple symbols) rhesus macaques. Note that these animals are distinct from the animals shown in (<bold>A</bold>). Each SIV uninfected and infected animal in (<bold>B</bold>) is represented by a unique symbol, with corresponding symbols in lymph nodes or intestinal tissue for the same animal being light or dark-colored, respectively. PBMC samples from SIV-infected animals were collected between 12 and 13 weeks post-infection, whereas lymph node and intestinal tissue samples of SIV-infected animals were collected between 4 and 9 weeks post-infection.</p></caption><graphic xlink:href="viruses-16-01839-g001" position="float"/></fig><fig position="float" id="viruses-16-01839-f002"><label>Figure 2</label><caption><p><bold>Promoter-wide CpG methylation changes in IFN&#x00263;, IL-2, and TNF&#x0237a; promoters of peripheral blood CD8<sup>+</sup> T cells post-versus pre-SIV infection</bold>. CpG methylation changes in the region of interest within IFN&#x00263; (<bold>A</bold>), IL-2 (<bold>B</bold>), and TNF&#x0237a; (<bold>C</bold>) gene promoters were quantitated pre- (blue symbols) and post- (orange symbols) SIV infection in paired peripheral blood CD8<sup>+</sup> T cells. The percentage of methylation of each animal was calculated as (methylated reads/total reads) &#x000d7; 100. Each matched symbol represents a unique animal, n = 4. Statistical significance was assessed by a two-tailed paired <italic toggle="yes">t</italic>-test in GraphPad Prism. PBMC samples from SIV-infected animals were collected between 12 and 13 weeks post-infection.</p></caption><graphic xlink:href="viruses-16-01839-g002" position="float"/></fig><fig position="float" id="viruses-16-01839-f003"><label>Figure 3</label><caption><p><bold>Promoter-wide methylation levels at the IFN&#x00263;, IL-2, and TNF&#x0237a; promoters in lymph node and intestinal tissue derived CD8<sup>+</sup> T cells from SIV uninfected and infected rhesus macaques</bold>. Methylation levels of select region of the IFN&#x00263; (<bold>A</bold>), IL-2 (<bold>B</bold>), and TNF&#x0237a; (<bold>C</bold>) gene promoters were compared between lymph node (light-colored symbols) and intestinal tissue (dark-colored symbols) derived CD8<sup>+</sup> T cells within SIV-uninfected (green and olive symbols, n = 4) and SIV-infected (pink and purple symbols, n = 3) animals. Data represent the mean and standard deviation in methylation of all the animals per group, with each animal being represented by unique symbols. Statistical differences between mean methylation percentages of the same CD8<sup>+</sup> T cell cytokine promoter across different tissues in the same animal were calculated by a two-tailed paired <italic toggle="yes">t</italic>-test in GraphPad Prism. No statistically significant differences were observed in comparisons based on infection status, i.e., the methylation of the same cytokine promoter was compared between CD8<sup>+</sup> T cells of the same tissue type in SIV-uninfected compared to SIV-infected animals (significance calculated by Mann&#x02013;Whitney test in GraphPad Prism, see <xref rid="viruses-16-01839-t005" ref-type="table">Table 5</xref> for results). Lymph node and intestinal tissue samples of SIV-infected animals were collected between 4 and 9 weeks post-infection.</p></caption><graphic xlink:href="viruses-16-01839-g003" position="float"/></fig><fig position="float" id="viruses-16-01839-f004"><label>Figure 4</label><caption><p><bold>Site-specific methylation of CpG residues within the IFN&#x00263; and IL-2 promoter regions of CD8<sup>+</sup> T cells isolated from PBMC, lymph nodes, and intestinal tissues of SIV-uninfected and SIV-infected infant rhesus macaques.</bold> Methylation levels were measured for each CpG residue within the selected region of the IFN&#x00263; (<bold>A</bold>&#x02013;<bold>C</bold>) and IL-2 (<bold>D</bold>&#x02013;<bold>F</bold>) promoters of CD8<sup>+</sup> T cells derived from different tissues. Panel (<bold>A</bold>): The change in methylation post- (orange symbols) versus pre- (blue symbols) SIV infection at each CpG site within the same animal (each symbol represents a unique animal, n = 4). Statistical significance was assessed by a two-tailed paired <italic toggle="yes">t</italic>-test in GraphPad Prism. Panels (<bold>B</bold>,<bold>C</bold>): Methylation levels of each CpG site in SIV uninfected (green and olive symbols, n = 4) and infected (pink and purple symbols, n = 3) macaque CD8<sup>+</sup> T cells derived from lymph nodes (light-colored symbols) (<bold>B</bold>) or intestinal tissues (dark-colored symbols) (<bold>C</bold>), respectively. Data represent the mean and standard deviation in methylation of all the animals per group, with each animal being represented by unique symbols in panels (<bold>B</bold>,<bold>C</bold>). Statistically significant differences were calculated by the Mann&#x02013;Whitney test in GraphPad Prism for panels (<bold>B</bold>,<bold>C</bold>). Panels (<bold>D</bold>&#x02013;<bold>F</bold>) are analogous to panels (<bold>A</bold>&#x02013;<bold>C</bold>) but illustrate methylation at CpG sites in the IL-2 promoter. PBMC samples from SIV-infected animals were collected between 12 and 13 weeks post-infection, whereas lymph node and intestinal tissue samples of SIV-infected animals were collected between 4 and 9 weeks post-infection.</p></caption><graphic xlink:href="viruses-16-01839-g004" position="float"/></fig><fig position="float" id="viruses-16-01839-f005"><label>Figure 5</label><caption><p><bold>Site-specific methylation levels of CpG residues within the TNF&#x0237a; promoter region of CD8<sup>+</sup> T cells isolated from PBMCs, lymph nodes, and intestinal tissues of SIV-uninfected and SIV-infected infant rhesus macaques.</bold> Methylation levels were measured for each CpG residue within the selected region of the TNF&#x0237a; (<bold>A</bold>&#x02013;<bold>C</bold>) promoter of CD8<sup>+</sup> T cells derived from different tissues. Panel (<bold>A</bold>): The change in methylation post- (orange symbols) versus pre- (blue symbols) SIV infection at each CpG site within the same animal (each symbol represents a unique animal, n = 4). Statistical significance was assessed by a two-tailed paired <italic toggle="yes">t</italic>-test in GraphPad Prism. &#x0201c;*&#x0201d; denotes statistical significance at <italic toggle="yes">p</italic> value &#x0003c;0.05 with exact <italic toggle="yes">p</italic> values stated on the graph. Panels (<bold>B</bold>,<bold>C</bold>): Methylation levels of each CpG site in SIV uninfected (green and olive symbols, n = 4) and infected (pink and purple symbols, n = 3) macaque CD8<sup>+</sup> T cells derived from lymph nodes (light-colored symbols) (<bold>B</bold>) or intestinal tissues (dark-colored symbols) (<bold>C</bold>), respectively. Data represent the mean and standard deviation in methylation of all the animals per group, with each animal being represented by unique symbols in panels (<bold>B</bold>,<bold>C</bold>). No statistically significant differences were observed in panels (<bold>B</bold>,<bold>C</bold>) by the Mann&#x02013;Whitney test in GraphPad Prism. PBMC samples from SIV-infected animals were collected between 12 and 13 weeks post-infection, whereas lymph node and intestinal tissue samples of SIV-infected animals were collected between 4 and 9 weeks post-infection.</p></caption><graphic xlink:href="viruses-16-01839-g005" position="float"/></fig><fig position="float" id="viruses-16-01839-f006"><label>Figure 6</label><caption><p><bold>Tissue-specific differences in CpG site-specific methylation levels within cytokine promoter regions of CD8<sup>+</sup> T cells isolated from lymph nodes or intestinal tissues in SIV-uninfected and SIV-infected rhesus macaques.</bold> Methylation levels were measured for each CpG residue within the selected region of the IFN&#x00263; (<bold>A</bold>,<bold>B</bold>), IL-2 (<bold>C</bold>,<bold>D</bold>), or TNF&#x0237a; (<bold>E</bold>,<bold>F</bold>) promoters of CD8<sup>+</sup> T cells derived from lymph nodes (light-colored symbols) and intestinal tissues (dark-colored symbols), respectively. Each symbol represents an individual animal with tissues from SIV-uninfected (green and olive symbols, n = 4) or SIV-infected (pink and purple symbols, n = 3) animals. The data represent the mean and standard deviation in methylation of all the animals per group, with each animal being represented by unique symbols. Statistical significance was determined by a two-tailed paired <italic toggle="yes">t</italic>-test in GraphPad Prism. Lymph node and intestinal tissue samples of SIV-infected animals were collected between 4 and 9 weeks post-infection.</p></caption><graphic xlink:href="viruses-16-01839-g006" position="float"/></fig><table-wrap position="float" id="viruses-16-01839-t001"><object-id pub-id-type="pii">viruses-16-01839-t001_Table 1</object-id><label>Table 1</label><caption><p>Study Animals.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tissue Type/Animal</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age (Wks)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tissue</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SIV Status</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Wks PI <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Viremia at the Time of Sampling<break/>(RNA Copies/mL)</th></tr></thead><tbody><tr><td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">PBMC <sup>b</sup>&#x02014;Pre- and post-SIV infection</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM <sup>c</sup> 1</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">PBMC</td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Positive</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 2</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">PBMC</td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Positive</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7 &#x000d7; 10<sup>6</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 3</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">PBMC</td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Positive</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 4</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">PBMC</td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.4 &#x000d7; 10<sup>6</sup></td></tr><tr><td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Tissues&#x02014;SIV-uninfected</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 5</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">LN <sup>d</sup>, INT <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 6</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">LN, INT</td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 7</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">LN, INT</td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RM 8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LN, INT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Tissues&#x02014;SIV-infected</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 9</td><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">LN, INT</td><td align="center" valign="middle" rowspan="1" colspan="1">Positive</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4 &#x000d7; 10<sup>8</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RM 10</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">LN, INT</td><td align="center" valign="middle" rowspan="1" colspan="1">Positive</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">8.7 &#x000d7; 10<sup>7</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RM 11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LN, INT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.0 &#x000d7; 10<sup>7</sup></td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> PI = post-infection; <sup>b</sup> PBMC = peripheral blood mononuclear cells; <sup>c</sup> RM = rhesus macaque; <sup>d</sup> LN = lymph nodes; <sup>e</sup> INT = intestinal tissues.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="viruses-16-01839-t002"><object-id pub-id-type="pii">viruses-16-01839-t002_Table 2</object-id><label>Table 2</label><caption><p>Primer sequences for bisulfite sequencing.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target<break/>(GenBank No.)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence (5&#x02032;-3&#x02032;)<break/>(Position&#x02014;Input Sequence Used for Primer Design *)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amplicon Size</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-2 promoter<break/>(EF457241)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F<break/><break/>R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGGTAAAGATATAAAAATGAGAAATATGGATTGG<break/>(143&#x02013;171)<break/>ATATAAATAAAATCCCTCATAATTACATTAACCCAC<break/>(741&#x02013;706)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">597 bp</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN&#x003b3; promoter (AY486428.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F<break/><break/>R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AATGTGTTTTGTGAATGAGGAGTTAATATTTTATTAGG<break/>(412&#x02013;449)<break/>AACTTAACTAATCTTTCTCTTCTAATAACTAATCTTC<break/>(763&#x02013;799)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">387 bp</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF&#x003b1; promoter<break/>(AY486430)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F<break/><break/>R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGGAGGAYGGGATTTAATTTTTAGAG<break/>(649&#x02013;674)<break/>AAAATCTAAAATTACTTCTCTCCCTCTTAAC<break/>(963&#x02013;992)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">343 bp</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> F = forward, R = reverse. * see <xref rid="app1-viruses-16-01839" ref-type="app">Supplementary Material S2</xref> for primer location.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="viruses-16-01839-t003"><object-id pub-id-type="pii">viruses-16-01839-t003_Table 3</object-id><label>Table 3</label><caption><p>Selected regions of cytokine promoters.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cytokine<break/>Promoter</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gen Bank No.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Promoter Region of Interest * (Size)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No. of CpGs in Assessed Promoter Region</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EF45724</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">530&#x02013;1127 (597 bp)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN&#x003b3;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AY486428.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">412&#x02013;799 (387 bp)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF&#x003b1;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AY486430</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">649&#x02013;992 (343 bp)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td></tr></tbody></table><table-wrap-foot><fn><p>* Promoter Region of Interest- position mentioned with respect to the 1st base pair of promoter sequence for each cytokine per NCBI.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="viruses-16-01839-t004"><object-id pub-id-type="pii">viruses-16-01839-t004_Table 4</object-id><label>Table 4</label><caption><p>Predicted transcription factor binding sites in selected regions of cytokine promoters.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cytokine<break/>Promoter</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CpG Site Position <break/>from TSS <sup>a</sup></th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TF <sup>b</sup> Binding Sites Coinciding with or in Close Proximity to CpG Sites</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">IL-2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;306</td><td align="left" valign="middle" rowspan="1" colspan="1">C/EBPbeta, XBP-1, GR-beta, Foxp3, HNF-1C, HNF-1A, HNF-1B, C/EBP alpha, POU2F1, POU2F2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;644</td><td align="left" valign="middle" rowspan="1" colspan="1">C/EBP beta, GR-alpha, GR-beta, HNF-3A, PR-B, PR-A, MEF-2A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;702</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C/EBP beta, XBP-1, GR-beta, Foxp3, PR-B, PR-A, C/EBP alpha</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">IFN&#x003b3;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;183</td><td align="left" valign="middle" rowspan="1" colspan="1">GR-beta, GR-alpha, TFII-1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;315</td><td align="left" valign="middle" rowspan="1" colspan="1">GR-alpha, C/EBP beta, LEF1, NFAT2, NCI/CTF, SRY, TCF-4E, GR, RXR-alpha, NF-1, TCF4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;410</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GR beta, TFIID (T00820), GR-alpha, NFAT2, TFII-1, NFKB, C/EBP beta, STAT4, c-ETS1, STAT1beta, HNF-3alpha, NFAT1, IRF1</td></tr><tr><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">TNF&#x003b1;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;172</td><td align="left" valign="middle" rowspan="1" colspan="1">C/EBP beta, GR-alpha, TFII-1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;201</td><td align="left" valign="middle" rowspan="1" colspan="1">C/EBP beta, Foxp3, GR, c-Myb, PR-B, PR-A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;220</td><td align="left" valign="middle" rowspan="1" colspan="1">GR-alpha, TFII-1, PPAR-alpha: RXR-alpha, XBP-1, AR, TBP</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;228</td><td align="left" valign="middle" rowspan="1" colspan="1">GR-alpha, Pax-5, p53, PPAR-alpha: RXR-alpha, ETF, EBF</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;251</td><td align="left" valign="middle" rowspan="1" colspan="1">C/EBP beta, Foxp3, GR-beta, XBP-1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;298</td><td align="left" valign="middle" rowspan="1" colspan="1">GR-alpha, STAT4, c-Ets-1, Elk-1, PU.1, c-Ets2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;340</td><td align="left" valign="middle" rowspan="1" colspan="1">C/EBP beta, Foxp3, TFII-1, NFI/CTF</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;342</td><td align="left" valign="middle" rowspan="1" colspan="1">YY1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;348</td><td align="left" valign="middle" rowspan="1" colspan="1">Pax-5, p53, E2F-1, Sp1, WT1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;417</td><td align="left" valign="middle" rowspan="1" colspan="1">GR-alpha, TFII-1, PEA3, YY1, MAZ</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;423</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GR-alpha, TFII-1, GR-beta, STAT4, c-Ets1</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> TSS = transcription Start Site, <sup>b</sup> TF = Transcription Factor.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="viruses-16-01839-t005"><object-id pub-id-type="pii">viruses-16-01839-t005_Table 5</object-id><label>Table 5</label><caption><p>Cytokine promoter-wide methylation comparison between SIV-uninfected and infected animals in CD8<sup>+</sup> T cells isolated from lymph node and intestinal tissues.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tissue Type/Cytokine Promoter</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Median Methylation SIV-Na&#x000ef;ve Animals (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Median Methylation SIV-Infected Animals (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">95% Confidence Interval of Difference Between Median</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value <sup>a</sup></th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lymph node/IL-2 Promoter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;8.7 to 7.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.9999</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal tissue/IL-2 Promoter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;6.9 to 11.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.9999</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lymph node/IFN&#x003b3; Promoter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;12.8 to 17.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6286</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal tissue/IFN&#x003b3; Promoter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;10.1 to 5.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6286</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lymph node/TNF&#x003b1; Promoter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;12.4 to 22.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4000</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal tissue/TNF&#x003b1; Promoter</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8 to 11.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0571</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Mann&#x02013;Whitney test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>